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Abstract	  
Those	   with	   epilepsy	   have	   a	   higher	   risk	   of	   sudden	   death	   than	   the	   general	   population;	  
however,	  the	  mechanism	  of	  these	  sudden	  deaths	  is	  unknown.	  	  Fatal	  arrhythmia	  generation	  during	  
seizure,	   along	   with	   changes	   in	   autonomic	   tone,	   are	   hypothesised	   to	   be	   important	   factors.	   	   Six	  
Wistar	   rats	   were	   stereotaxically	   injected	   with	   tetanus	   toxin	   into	   the	   ventral	   hippocampus,	   and	  
implanted	  with	  radiotelemeters	  to	  record	  electrocardiogram	  and	  electroencephalogram.	  	  The	  heart	  
rate	  was	  analysed	  in	  pre-­‐ictal,	  ictal	  and	  post-­‐ictal	  epochs	  with	  the	  aim	  of	  demonstrating	  the	  changes	  
in	  autonomic	  tone	  during	  seizure.	  	  Ictal	  bradycardia	  was	  observed	  in	  89%	  of	  the	  seizures	  analysed,	  
with	   post-­‐ictal	   tachycardia	   in	   93%.	   	   Further,	   potentially	   lethal	   arrhythmias	  were	   observed	   during	  
seizure.	  	  Missed	  beats	  (59%),	  ventricular	  premature	  depolarisation	  (22%)	  and	  ventricular	  fibrillation	  
(17%)	  are	  risk	  factors	  for	  sudden	  death	  in	  the	  general	  population	  and	  their	  presence	  during	  seizure	  
could	   potentially	   be	   fatal.	   	   Whilst	   this	   study	   has	   demonstrated	   changes	   in	   autonomic	   tone	   and	  
cardioarrhythmia	  generation;	  the	  extent	  of	  the	  changes	  and	  their	  mechanism	  need	  to	  be	  explored	  
further.	  	  Nevertheless,	  this	  research	  validates	  the	  tetanus	  toxin	  model	  of	  temporal	  lobe	  epilepsy	  as	  
a	  tool	  for	  investigating	  sudden	  death	  in	  epilepsy.	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Introduction	  
	   Around	  50	  million	  people	  worldwide	  suffer	  from	  epilepsy	  (WHO,	  2012),	  with	  the	  incidence	  in	  
developed	  countries	  50	  per	  100,000	  (Duncan	  et	  al.,	  2006).	  	  Epilepsy	  is	  a	  chronic	  disease	  of	  the	  brain	  
that	  is	  defined	  by	  recurring	  and	  unprovoked	  seizures,	  with	  many	  seizure	  types	  identified	  (Duncan	  et	  
al.,	   2006).	   	   The	  most	   destructive	   outcome	   of	   epilepsy	   is	   death.	   	   The	   risk	   of	   death	   in	   those	  with	  
epilepsy	  is	  two	  to	  three	  times	  higher	  than	  the	  general	  population	  (Donner,	  2011).	  	  Many	  deaths	  in	  
epilepsy	   can	   be	   attributed	   to	   the	   disease,	   where	   the	   death	   is	   linked	   to	   a	   seizure,	   however	   a	  
proportion	  are	  sudden	  and	  unexplained	   (Donner,	  2011).	   	   In	  a	   five-­‐year	  prospective	  study,	  18%	  of	  
deaths	  in	  the	  4,578	  patient	  cohort	  were	  deemed	  unexplained	  (Walczak	  et	  al.,	  2001).	  	  These	  deaths	  
have	  been	  collectively	  described	  as	  sudden	  unexplained/unexpected	  death	  in	  epilepsy	  (SUDEP).	  	  
What	  is	  SUDEP?	  
	  SUDEP	   is	   defined	   as	   deaths	   in	   epilepsy	   that	   are	   sudden,	   unexpected,	   non-­‐traumatic	   and	  
non-­‐drowning,	  witnessed	  or	  un-­‐witnessed,	  with	  or	  without	  evidence	  of	   a	   seizure	   (Donner,	  2011).	  	  
SUDEP	   is	   given	   as	   the	   cause	   of	   death	   when	   all	   other	   possible	   causes	   have	   been	   eliminated;	  
however,	   the	   poor	   awareness	   of	   pathologists,	   combined	   with	   lack	   of	   autopsy,	   has	   limited	   the	  
documented	   number	   of	   deaths	   classified	   as	   SUDEP	   (Donner,	   2011).	   	   As	   such,	   the	   true	   incidence	  
remains	  unknown.	  	  In	  many	  cases,	  “probable	  SUDEP”	  is	  used	  to	  describe	  those	  deaths	  which	  satisfy	  
the	  criteria	  above,	  but	  where	  no	  post-­‐mortem	  examination	  was	  available	  (Donner,	  2011;	  Annegers	  
and	  Coan,	  1999).	  
The	   incidence	  of	  SUDEP	  reported	   in	  different	  studies	   is	  extremely	  varied,	  as	   they	  differ	  on	  
the	  criteria	  of	  SUDEP	  used,	  the	  method	  of	  study,	  and	  the	  population	  studied	  (Tomson	  et	  al.,	  2008).	  	  
For	  example,	  Lhatoo	  et	  al.	  (2001)	  analysed	  newly	  diagnosed	  patients	  and	  showed	  an	  incidence	  rate	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of	  0.09	  per	  1000	  patient	  years,	  whereas	  Dasheiff	  et	  al.	  (1991)	  studied	  epilepsy	  surgery	  candidates	  
who	  had	  a	  SUDEP	  incidence	  rate	  of	  9.3	  per	  1,000	  patient	  years.	  	  Sillanpaa	  et	  al.	  (2010)	  found	  a	  7%	  
risk	  of	  SUDEP	  over	  a	  40-­‐year	  period	  of	  those	  with	  childhood	  onset	  epilepsy,	  and	  12%	  risk	  in	  those	  
not	   in	  five-­‐year	  remission.	   	  Children	  have	  a	   lower	   incidence	  of	  SUDEP	  compared	  with	  adults,	  with	  
the	  exception	  of	  those	  with	  Dravet	  syndrome1	  –	  which	  has	  a	  high	  reported	  rate	  of	  SUDEP	  (Tomson	  
et	  al.,	  2008).	  	  
SUDEP	  Risk	  Factors	  
Several	   risk	   factors	   have	   been	   identified	   for	   SUDEP.	   	   The	   most	   important	   of	   these	   is	  
experiencing	   frequent	   generalised	   tonic-­‐clonic	   seizures,	  with	   a	   history	   of	  more	   than	   three	   in	   the	  
previous	  12	  months	  (DeGiorgio	  et	  al.,	  2010;	  Donner,	  2011).	  	  Active	  epilepsy,	  where	  the	  patient	  has	  
failed	   to	   gain	   five-­‐year	   remission,	   is	   also	   a	  major	   risk	   factor	   (Donner,	   2010).	   	   Further	   to	   this,	   the	  
younger	   the	   age	   of	   onset	   and	   the	   longer	   duration	   (over	   30	   years)	   of	   epilepsy	   have	   been	  
demonstrated	  to	   increase	  the	  risk	  of	  SUDEP	  in	  adults	  (DeGiorgio	  et	  al.,	  2010;	  Donner,	  2011).	   	  The	  
use	  of	  anti-­‐epileptic	  drugs	  has	  also	  been	  identified	  as	  a	  risk	  factor.	  	  Polytherapy,	  defined	  as	  the	  use	  
of	   three	  or	  more	   anti-­‐epileptic	   drugs,	   increases	   the	   risk	   of	   SUDEP	  by	   8	   times	  when	   compared	   to	  
monotherapy	   (DeGiorgio	   et	   al.,	   2010;	   Donner,	   2011).	   	   In	   particular,	   two	   anti-­‐epileptic	   agents,	  
lamotrigine	  and	  carbamazepine,	  have	  been	   implicated	   in	  SUDEP	  as	   they	  both	  have	  effects	  on	   the	  
cardiovascular	  system	  (Aurlien	  et	  al.,	  2007;	  Nilsson	  et	  al.,	  2001).	  	  Firstly,	  carbamazepine	  was	  shown	  
to	   reduce	   heart	   rate	   variability	   -­‐	   a	   measure	   of	   autonomic	   tone	   -­‐	   in	   15	   patients	   with	   epilepsy	  
(Persson	  et	  al.,	  2003)	  implying	  that	  carbamazepine	  has	  an	  effect	  on	  the	  autonomic	  system	  as	  well	  as	  
its	   anti-­‐epileptic	   properties.	   	   Secondly,	   lamotrigine	   has	   been	   shown	   to	   inhibit	   the	   cardiac	   rapid	  
delayed	   rectifier	   potassium	   ion	   current	   (IKr),	   the	   blocking	   of	   which	   has	   been	   associated	   with	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
1	  Dravet	  syndrome,	  or	  Severe	  Myoclonic	  Epilepsy	  of	   Infants	   (SMEI),	   is	  a	  drug-­‐resistant	  epilepsy	  that	  occurs	  during	  the	  
first	  year	  of	  life.	  	  It	  is	  characterised	  by	  frequent	  convulsive	  febrile	  and	  non-­‐febrile	  seizures,	  frequent	  status	  epilepticus,	  
and	  a	  mortality	  rate	  of	  16%	  (Wolff	  et	  al.,	  2006).	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prolonged	  QT	   interval	   (Donner,	  2011).	   	   It	   is	  hypothesised	   that	   seizure	   induced	  metabolic	  acidosis	  
could	   result	   in	   a	   fatal	   arrhythmia	   when	   coupled	   with	   the	   reduced	   IKr	   current	   (Danielsson	   et	   al.,	  
2005).	  	  
Possible	  SUDEP	  Mechanisms	  	  
The	   mechanism,	   or	   mechanisms,	   which	   underpin	   SUDEP	   are	   currently	   unknown,	   with	   a	  
number	  of	  hypotheses	  proposed.	  	  Sudden	  death	  in	  the	  general	  population	  has	  been	  associated	  with	  
cardiac	  arrhythmias,	  and	  it	  has	  therefore	  been	  proposed	  that	  SUDEP	  is	  caused	  by	  fatal	  arrhythmia	  
generation.	   	   Premature	   ventricular	   depolarisation,	   premature	   atrial	   depolarisations	   and	  
atrioventricular	  block	  have	  all	  been	  observed	  during	  epileptic	  seizure	  (Opherk	  et	  al.,	  2002;	  Nei	  et	  al.,	  
2000;	  Zijlmans	  et	  al.,	  2002).	   	   It	  has	  been	  proposed	   that	   the	  cause	  of	   such	  arrhythmias	   is	   through	  
myocardial	  fibrosis	  and	  myofibrillar	  degeneration	  in	  the	  sino-­‐atrial	  node	  (Reichenbach	  and	  Benditt,	  
1970).	  	  Other	  changes	  that	  influence	  arrhythmia	  generation,	  such	  prolonged	  QTc	  (Damasceno	  et	  al.,	  
2013	  and	  Nei	  et	  al.,	  2000)	  and	  elevated	  ST	  segment	  (Nei	  et	  al.,	  2000;	  Opherk	  et	  al.,	  2002;	  Zijlmans	  et	  
al.,	  2002)	  have	  been	  associated	  with	  seizure,	  and	  therefore	  potentially	  with	  SUDEP.	  	  
Another	   hypothesis	   has	   emerged	  due	   to	   the	   similarity	   between	   SUDEP	   and	   sudden	   infant	  
death	   syndrome	   (SIDS).	   	   SIDS	   has	   been	   associated	   with	   a	   defect	   in	   the	   brainstem-­‐mediated	  
response	  to	  an	  increase	  partial	  pressure	  of	  carbon	  dioxide	  (Donner,	  2011).	   	  This	  respiratory	  arrest	  
could	   also	   be	   present	   in	   SUDEP	   as	   ictal	   respiratory	   depression	   has	   been	   observed	   in	   numerous	  
studies	   (Azar	   et	   al.,	   2008;	   Blum,	   2009),	   with	   a	   decrease	   in	   oxygen	   saturation	   in	   33%	   of	   seizures	  
analysed	  by	  Bateman	  et	  al.	  (2010).	  	  
The	  current	  focus	  of	  research	  into	  the	  effect	  of	  seizure	  on	  the	  cardiovascular	  system	  centres	  
on	   autonomic	   dysfunction,	   highlighting	   ictal	   tachycardia	   or	   bradycardia.	   	   Sudden	   death	   in	   the	  
general	   population	   has	   been	   associated	   with	   autonomic	   dysfunction,	   with	   in	   vivo	   studies	  
highlighting	   the	   role	   of	   the	   sympathetic	   nervous	   system	   in	   fatal	   arrhythmia	   generation,	   with	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patients	   with	   high	   levels	   of	   circulating	   noradrenalin	   having	   an	   increased	   risk	   of	   sudden	   death	  
(Murray	  and	  Roden,	  1996).	  	  	  
Previous	   unpublished	  work	   from	   this	   group	   (Vivian-­‐Griffiths,	   2012)	   showed	   that	   electrical	  
intrahippocampal	  stimulation	  of	  terminally	  anaesthetised	  rats	  at	  20	  and	  40	  Hz	  caused	  a	  decrease	  in	  
heart	  rate.	  	  Ictal-­‐bradycardia	  has	  also	  been	  observed	  in	  a	  number	  of	  other	  studies,	  with	  Mameli	  et	  
al.	   (1993)	  producing	  bradyarrhythmic	  episodes,	   lasting	  up	  to	  15	  s,	  by	  applying	  penicillin	  G	  -­‐	  which	  
can	   trigger	  epileptic	   seizures	   -­‐	  directly	  onto	   the	   thalamus	  and	  hypothalamus.	   	  Hotta	  et	  al.	   (2009)	  
showed	   that	   vagal	   stimulation	   with	   patterns	   based	   on	   recording	   made	   from	   the	   vagus	   during	  
seizure,	  induced	  a	  decrease	  in	  Wistar	  rats’	  heart	  rate	  by	  around	  100	  beats	  per	  minute	  (bpm).	  	  Sinus	  
bradycardia	   has	   also	   been	   shown	   in	   humans	   by	   Nei	   et	   al.	   (2000),	   Rocamora	   et	   al.	   (2003)	   -­‐	   who	  
observed	  asystole	  and	  bradycardia	  in	  5	  patients	  -­‐	  and	  So	  et	  al.	  (2000)	  -­‐	  who	  observed	  bradycardia	  
and	  apnoea	   in	  a	  woman	  with	  epilepsy.	   	  Bradycardia	  could	  also	   lead	   to	   the	  arrhythmias	  discussed	  
above	  as	  the	  slowing	  of	  the	  pacemaker	  potential	  -­‐	  induced	  by	  increased	  vagal	  activity	  –	  reduces	  the	  
action	  potential	  duration	  and	  refractory	  period	  in	  the	  atria.	  	  This	  can	  in	  turn	  increase	  excitability	  of	  
myocytes	  making	  them	  more	  susceptible	  to	  local	  abnormal	  currents.	  	  
Conversely,	   other	   studies	   have	   shown	   elevated	   heart	   rates	   associated	   with	   seizure.	  	  
Damasceno	   et	   al.	   (2013),	   using	   Wistar	   audiogenic	   rats,	   showed	   elevated	   basal	   heart	   rate	   and	  
prolonged	  QT	  interval	  and	  QRS	  complex.	  	  Leutmezer	  et	  al.	  (2003)	  analysed	  the	  heart	  rate	  changes	  in	  
145	   seizures	   across	   58	   patients,	   and	   found	   ictal	   tachycardia	   in	   86.9%	   of	   all	   seizures,	   with	  
bradycardia	   only	   seen	   in	   1.4%.	   	   It	   was	   also	   found	   that	   there	   was	   a	   difference	   in	   the	   temporal	  
relationship	  between	   the	   tachycardia	   and	   seizure	  onset,	  with	   the	   change	   in	  heart	   rate	  preceding	  
110	   seizures,	  occurring	   simultaneously	   in	   five	   seizure	  and	  post-­‐ictally	   in	  30	   seizures.	   	   This	   finding	  
implies	  that	  autonomic	  dysfunction	  could	  be	  caused	  by	  epileptic	  discharges	  that	  precede	  seizure.	  	  
Tachycardia	  was	  also	  seen	  by	  Opherk	  et	  al.	  (2002)	  who	  retrospectively	  analysed	  changes	  in	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heart	   rate	   in	   102	   seizures	   from	   41	   patients.	   	   99%	   of	   seizures	   led	   to	   tachycardia	   and	   potentially	  
serious	  electrocardiograph	  (ECG)	  changes	  -­‐	  such	  as	  ST-­‐segment	  elevation	  and	  prolonged	  QT	  interval	  
-­‐	  were	  observed	   in	  6%	  of	   seizures.	   	   Tigaran	  et	  al.	   (2003)	  also	  demonstrated	   ictal	   tachycardia	   in	  a	  
human	  study	  of	  patients	  with	  drug	  refractory	  epilepsy.	  	  Finally,	  Zijlmans	  et	  al	  (2002)	  has	  shown,	  in	  a	  
retrospective	  study,	  an	  increase	  in	  heart	  rate	  by	  at	  least	  10	  bpm	  in	  73%	  of	  the	  281	  seizures	  analysed	  
Zijlmans	   et	   al.	   (2002)	   also	   demonstrated	   the	   temporal	   relationship	   shown	   by	   Leutmezer	   et	   al.	  
(2003),	  and	  also	  demonstrated	  bradycardia	  in	  7%	  of	  seizures.	  	  
It	   is	   clear	   that	   the	   current	   literature	   is	   divided	   as	   to	   the	   effect	   of	   seizure	   on	   the	  
cardiovascular	   system.	   	   It	   is	   apparent	   that	   arrhythmia	   generation	   is	   common;	   however,	   the	  
direction	  of	  change	  in	  the	  heart	  rate	  is	  not	  consistent.	   	  The	  cause	  of	  these	  cardiovascular	  changes	  
has	   been	   attributed	   to	   autonomic	   dysfunction,	   which	   needs	   to	   be	   explored	   further	   in	   order	   to	  
describe	  the	  mechanisms	  by	  which	  this	  dysfunction	  occurs.	  	  To	  explore	  the	  ictal	  autonomic	  changes	  
in	  vivo,	  tetanus	  toxin	  shall	  be	  injected	  intrahippocampally	  to	  model	  temporal	  lobe	  epilepsy.	  	  
Tetanus	  Toxin	  Model	  of	  Temporal	  Lobe	  Epilepsy	  
The	   tetanus	   toxin	   (TeNT)	   model	   of	   temporal	   lobe	   epilepsy	   uses	   the	   neurotoxin	   from	  
Clostridium	   tetani	   to	   induce	   a	   chronic	   state	   of	   epilepsy,	   characterised	   by	   repeated	   seizures,	   via	  
intrahippocampal	  injection.	  	  TeNT	  models	  different	  types	  of	  epilepsy	  dependent	  on	  the	  location	  of	  
the	   injection	   by	   selectively	   cleaving	   vesicle	   associated	  membrane	   proteins	   in	   the	   γ-­‐aminobutyric	  
acid	  (GABA)	  interneurons.	  	  For	  example,	  a	  neocortical	  injection	  will	  model	  focal	  neocortical	  seizures,	  
whereas	  a	  hippocampal	  injection	  models	  temporal	   lobe	  epilepsy	  (Jefferys	  and	  Walker,	  2006).	   	  The	  
use	   of	   intrahippocampal	   injections	   have	   been	   extensively	   used	   by	   this	   lab	   (Jefferys	   et	   al.,	   1992;	  
Jiruska	  et	  al.,	  2010;	  Jiruska	  et	  al.,	  2013)	  and	  others	  (Mellanby	  et	  al.,	  1977;	  1982)	  
TeNT	  is	  a	  zinc	  metalloprotease	  with	  two	  components:	  (1)	  a	  light	  chain	  -­‐	  which	  is	  responsible	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for	   the	   proteolytic	   activity	   -­‐	   and	   (2)	   a	   heavy	   chain	   -­‐	   which	   is	   responsible	   for	   the	   binding	   and	  
internalisation	  of	  the	  neurotoxin	  (Farrar	  et	  al.,	  2000;	  Jefferys	  and	  Walker	  2005).	  	  By	  preventing	  the	  
inhibitory	  activity	  of	  the	  GABAergic	  neurones,	  a	  localised	  increase	  in	  excitatory	  activity	  occurs	  that	  
can	   cause	   a	   partial	   seizure	   to	   globalise	   and	   manifest	   as	   a	   generalised	   seizure.	   	   High	   doses	   of	  
intracranial	   toxin	  have	  been	  shown	  to	   result	   in	  cell	  death	  and	  a	  high	  mortality	   rate,	  whereas	   low	  
doses	  (5	  ng	  in	  1	  μl)	  typically	   induce	  minimal	  cell	   loss,	  no	  major	  morphological	  changes	  (Jefferys	  el	  
al.,	  1992;	  Jiruska	  et	  al.,	  2010)	  and	  do	  not	  induce	  status	  epilepticus	  at	  any	  stage	  (Jefferys	  and	  Walker,	  
2006;	  Jiruska	  et	  al.,	  2013).	  	  
The	  model	   is	   reliable	  with	   seizure	   onset	   approximately	   three	   to	   eight	   days	   post	   injection,	  
with	  generalised	  seizures	  observed	  a	  few	  days	   later.	   	  At	  their	  peak,	  seizures	  can	  happen	  up	  to	  30	  
times	  per	  day,	  and	  are	  rarely	  beyond	  two	  minutes	  in	  duration	  (Jefferys	  and	  Walker,	  2006;	  Jiruska	  et	  
al.,	  2013).	  	  Seizures	  persist,	  with	  animals	  gaining	  remission	  six	  to	  eight	  weeks	  after	  onset	  (Jiruska	  et	  
al.,	  2013).	  	  The	  clinical	  and	  behavioural	  features	  of	  the	  TeNT	  model	  of	  temporal	  lobe	  epilepsy	  have	  
been	  well	  characterised.	  	  Seizures	  start	  with	  behavioural	  arrest	  and	  whisker	  twitching,	  continuing	  to	  
forelimb	  movements	  and	  onto	  rearing	  and	  falling	  (Jefferys	  and	  Walker,	  2006).	  	  	  
Ventral	  Hippocampus	  and	  the	  Cardiovascular	  System	  
Two	  injection	  sites	  are	  typically	  used	  for	  the	   induction	  of	  epileptic	  seizures	  using	  TeNT:	  (1)	  
dorsal	   hippocampus	   (Jiruska	   et	   al.,	   2010;	   Jiruska	   et	   al.,	   2013)	   and	   (2)	   ventral	   hippocampus	  
(Mellanby	  et	   al.,	   1977;	  1982).	   	   This	   study	   injected	  TeNT	   into	   the	  ventral	  hippocampus,	  due	   to	   its	  
association	  with	  the	  autonomic	  nervous	  system.	  	  The	  hippocampus	  is	  connected	  electrically	  to	  the	  
hypothalamus	  by	  a	  C-­‐shaped	  bundle	  of	   fibres:	   the	   fornix	   (Bear	  et	   al.,	   2007).	   	   The	  paraventricular	  
hypothalamic	   nuclei	   in	   the	  hypothalamus	  have	  projections	   to	   the	  brainstem,	   namely	   the	  nucleus	  
tractus	  solitarius	  (NTS),	  the	  dorsal	  vagal	  nucleus	  (DVN)	  and	  the	  nucleus	  ambiguus	  (NA;	  Mosqueda-­‐
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Garcia,	   1996).	   	   These	   nuclei	   form	   the	   cardiovascular	   control	   centres,	   and	   have	   both	  
parasympathetic,	  via	  the	  vagal	  nerve,	  and	  sympathetic	  efferents,	  via	  the	  glutamatergic	  bulbospinal	  
pathway,	  to	  the	  cardiovascular	  system	  (Barrett	  et	  al.,	  2010).	  	  	  
Amongst	  others,	  the	  NTS	  is	  involved	  in	  cardiovascular	  homeostasis	  in	  normal	  conditions	  and	  
receives	  inputs	  from	  the	  baroreceptor	  and	  chemoreceptors	  of	  the	  carotid	  sinus	  and	  aortic	  arch,	  and	  
depending	  on	  the	  arterial	  blood	  pressure	  or	  the	  partial	  pressure	  of	  oxygen,	  will	  induce	  a	  change	  in	  
the	  cardiovascular	   system.	   	  For	  example,	  a	  decrease	   in	   the	  afferent	  activity	  of	   the	  baroreceptors,	  
induced	  by	  a	  decrease	  in	  arterial	  blood	  pressure,	  results	  in	  increased	  sympathetic	  outflow	  from	  the	  
NTS	   to	   the	   heart	   and	   vasculature,	   resulting	   in	   an	   increased	   blood	   pressure	   from	   the	   increase	   in	  
heart	  rate	  and	  induced	  vasoconstriction	  (Barrett	  et	  al.,	  2010;	  Stanfield,	  2011).	  	  Therefore,	  injecting	  
TeNT	  into	  the	  ventral	  hippocampus	  could	  replicate	  the	  autonomic	  dysfunction	  seen	  in	  both	  animal	  
and	  human	  studies	  (described	  above).	  	  
Study	  Aim	  	  
This	  study	  will	  primarily	  explore	  whether	  or	  not	  epileptic	  seizure,	  induced	  by	  tetanus	  toxin,	  
provokes	  a	  change	  to	  the	  cardiovascular	  system.	  	  The	  direction	  and	  magnitude	  of	  any	  cardiovascular	  
change	  will	  be	  analysed,	  along	  with	  the	  duration	  of	  this	  change.	   	  Finally,	  any	  arrhythmias	   induced	  
will	   be	   analysed.	   	   This	   study	   shall	   also	   refine	   the	   methods	   used	   to	   explore	   the	   effect	   on	   the	  
cardiovascular	  system	  and	  validate	  the	  use	  of	  tetanus	  toxin	  as	  a	  model	  of	  exploring	  SUDEP.	  	  	  
Study	  Hypothesis	  	  
	   Tetanus	   toxin	   will	   induce	   epileptic	   seizures	   and	   these	   seizures	   will	   affect	   the	   autonomic	  
control	   of	   the	   cardiovascular	   system,	   and	   elicit	   ictal	   tachycardia	   or	   bradycardia,	   along	   with	  
cardioarrhythmias.	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Method	  
	   This	  study	  was	  performed	  under	  John	  Jefferys’	  Project	  Licence	  (40/3635)	  and	  in	  accordance	  
with	  Home	  Office	  regulations.	  	  
In	   total,	  8	  Wistar	   rats	   (260	  ±	  14	  g;	  Charles	  River,	  UK)	  were	  used	   in	   this	   study.	   	  All	  animals	  
were	  housed,	   in	   compliance	  with	   the	  Animals	   (Scientific	   Procedures)	  Act	   1986,	   in	   the	  Biomedical	  
Services	  Unit	  at	  the	  University	  of	  Birmingham,	  on	  a	  12h:12h	  light:	  dark	  cycle	  with	  food	  and	  water	  
available	  ad	  libitum.	  	  Each	  animal	  was	  housed	  with	  a	  naïve	  companion	  rat	  in	  a	  plastic	  vivarium	  and	  
were	  monitored	  daily	  for	  epileptic	  activity	  (categorised	  using	  the	  Racine	  scale;	  see	  Racine,	  1972	  and	  
D’Ambrosio	  and	  Miller,	  2010).	  	  
Experimental	  Design	  
	   	  Two	   radiotelemetry	   systems	  were	   employed	   in	   this	   study.	   	   Two	   animals	  were	   implanted	  
with	   Data	   Science	   International	   (DSI,	   US)	   radiotelemeters	  while	   six	   animals	  were	   implanted	  with	  
Telemetry	  Research	  (TR)	  radiotelemeters	  (TR50BB;	  Millar	  Instruments,	  US).	  	  
Surgery	  
All	   surgeries	  were	  performed	  by	   Professor	   John	   Jefferys	   in	   the	  BMSU	  at	   the	  University	   of	  
Birmingham.	   	  Each	  animal	  was	  anaesthetised	  using	   isoflurane	   (5%	   induction,	  1.5-­‐3%	  maintenance	  
with	  oxygen	  at	  1	  Litre	  min-­‐1).	   	  Throughout	  each	  surgery	  the	  animal’s	  oxygen	  saturation,	  breathing	  
and	  heart	  rate	  and	  were	  monitored,	  with	  appropriate	  adjustments	  made	  to	  the	  level	  of	  anaesthesia	  
to	   correct	   any	   deviations	   from	   normal.	   	   Furthermore,	   the	   animal’s	   rectal	   temperature	   was	  
maintained	  at	  36-­‐37°C	  using	  a	  heating	  pad.	  	  
The	  two	  radiotelemeter	  systems	  used	  in	  this	  study	  meant	  that	  the	  surgery	  required	  for	  each	  
differed	   slightly.	   	   The	   DSI	   radiotelemeters	   used	   are	   smaller	   than	   the	   TR	   radiotelemeters,	   and	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therefore,	  the	  location	  where	  they	  were	  implanted	  differed.	  	  DSI	  radiotelemeters	  can	  be	  placed	  in	  a	  
subcutaneous	   cavity	   -­‐	   created	   by	   blunt	   dissection	   -­‐	   on	   the	   animal’s	   back,	   whereas	   TR	  
radiotelemeters	  must	   first	   be	   placed	   in	   a	   sterilised	   surgical	   mesh	   pouch	   and	   then	   placed	   in	   the	  
animal’s	   abdominal	   cavity.	   	   For	   both	   radiotelemeter	   types,	   the	   electrode	   wires	   were	   tunnelled	  
subcutaneously	  from	  the	  radiotelemeter’s	  location	  to	  the	  thorax	  and	  cervical	  region	  for	  the	  ECG	  and	  
EEG	  respectively.	  	  Each	  telemeter	  was	  sterilised	  before	  implantation.	  	  	  
The	   two	  DSI	   animals	  were	   subjected	   to	   a	   single	   surgery	   -­‐	  where	   TeNT	  was	   stereotaxically	  
injected	   into	   the	   ventral	   hippocampus	   (Table	   1)	   and	   the	   radiotelemeter	   implanted	   concurrently.	  	  
The	  TR	  animals	   required	   two	  separate	  surgeries	   for	   the	  animals	  using	  TR	  radiotelemeters.	   	   In	   the	  
first	   surgery,	   the	   TR	   radiotelemeter	   was	   placed	   into	   the	   abdomen,	   the	   EEG	   and	   ECG	   electrodes	  
placed	  as	  described	  below	  and	  a	  steel	  cannula	  was	  implanted	  over	  the	  ventral	  hippocampus.	  	  In	  the	  
subsequent	   surgery,	   7-­‐15	   days	   later,	   1	   μL	   of	   2%	   bovine	   serum	   albumin	   (Sigma-­‐Aldrich,	   UK)	   in	  
phosphate	  buffered	  saline	  (Sigma-­‐Aldrich	  UK)	  with	  (n=4)	  or	  without	  (vehicle	  controls;	  n=2)	  TeNT	  (1-­‐	  
5	  ng)	  was	  injected	  into	  the	  ventral	  hippocampus,	  via	  the	  indwelling	  cannula.	  	  
ECG	  and	  EEG	  electrode	  placement	  	  
The	  ECG	  electrodes	  were	  implanted	  into	  the	  muscle	  on	  the	  ventral	  aspect	  of	  the	  thorax	  over	  
the	  rib	  cage	  by	  the	  right	  shoulder	  (negative	  electrode)	  and	  the	  lower	  left	  chest	  (positive	  electrode;	  
as	   described	   by	   Kramer	   et	   al.,	   1993).	   	   A	   sterile	   hypodermic	   needle	   was	   used	   to	   tunnel	   into	   the	  
muscle,	   through	  which	   the	  electrode	  was	   threaded	   (as	  described	  by	  Tontodonati	  et	  al.,	  2011	  and	  
Kramer	   et	   al.,	   1993)	   and	   then	   sutured	   in	   place	   using	   non-­‐absorbable	   suture.	   	   A	   small	   plastic	   cap	  
(Data	   Science	   International,	   US)	   was	   placed	   over	   the	   exposed	   wire	   tip	   and	   sutured	   in	   place	   to	  
prevent	  it	  damaging	  neighbouring	  tissue.	  
The	   rat	   was	   placed	   into	   a	   stereotaxic	   frame,	   the	   skull	   exposed	   and	   EEG	   electrodes	   were	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placed	   into	   two	   burr	   holes,	   drilled	   using	   a	   micro-­‐drill	   (Circuit	   Medic,	   US),	   in	   the	   approximate	  
positions	  shown	  in	  Figure	  1.	  	  The	  end	  of	  each	  electrode	  wire	  was	  bent	  into	  a	  U-­‐shape,	  with	  the	  base	  
of	  the	  wire	  placed	  into	  the	  burr	  hole	  and	  held	  in	  place	  using	  bone	  cement	  whilst	  ensuring	  the	  wire	  




	   Each	  cannula	  was	  made	  in-­‐house	  to	  the	  specifications	  shown	  in	  Figure	  2,	  so	  that	  is	  rested	  on	  
the	  cortical	  surface.	  	  Each	  cannula	  was	  placed	  into	  a	  burr	  hole	  drilled	  at	  the	  coordinates	  in	  Table	  1,	  
using	   a	   pin	   chuck	   under	   stereotaxic	   control.	   	   By	   noting	   the	   final	   resting	   position	   below	   cortical	  
surface,	   this	   allowed	   the	   subsequent	   stereotaxic	   injection	   to	   be	  made	   as	   accurately	   as	   possible.	  	  
Each	  cannula	  was	  held	   in	  place	  using	  bone	  cement,	  which	  was	  extended,	   for	  stabilisation,	   to	   two	  
anchoring	  screws	  placed	  on	  the	  frontal	  bones	  (Figure	  1).	  	  
	  
	  
Figure	  1	  	  
(Adapted	   from	   Paxinos	   and	  Watson,	  1986)	   	   The	  approximate	  position	   of	   the	  5	   holes	   drilled.	   	   Horizontal	   lines	   ( )	  
denote	  the	  holes	  drilled	  for	  the	  anchoring	  screws,	  vertical	  lines	  show	  ( )	  the	  location	  of	  the	  EEG	  electrodes	  and	  the	  
black	  circle	  ( )	  is	  the	  approximate	  location	  of	  the	  hole	  drilled	  for	  the	  indwelling	  cannula.	  	  




In	  other	  experiments	  involving	  the	  dorsal	  hippocampus	  from	  this	  group,	  5	  ng	  of	  TeNT	  in	  1	  μL	  
PBS/BSA	  is	  used	  to	  induce	  epileptic	  seizures.	  	  However,	  when	  this	  dose	  was	  injected	  into	  the	  ventral	  
hippocampus	   it	   induced	   seizures	   with	   an	   exceptionally	   short	   latency	   period	   and	   intense	   seizure	  
activity.	   	  We	   subsequently	   used	  1	   ng	  of	   TeNT,	  which	  proved	   too	  mild	  with	   an	   exceptionally	   long	  
	  
	   Distance	  /	  mm	  
Anterior-­‐Posterior	  
(from	  Bregma)	   -­‐	  4.3	  	  
Medial-­‐Lateral	  
(from	  Bregma)	   ±	  4.4	  	  
Ventral	  Depth	  
(from	  cortical	  surface)	   -­‐	  7.5	  	  
Table	  1	  
	  Coordinates	  used	  for	  stereotaxic	  injection	  into	  the	  ventral	  hippocampus	  from	  Paxinos	  and	  Watson	  (1986).	  	  
	  
Figure	  2	  	  
The	  specifications	  for	  the	  indwelling	  cannula.	  	  Each	  cannula	  was	  made	  from	  a	  10	  mm	  21	  gauge	  stainless	  steel	  tube	  
with	   a	   small	   solder	   ball	   2	   mm	   from	  one	   end.	   	   This	   allowed	   the	   cannula	   to	   sit	   on	   the	   skull	   surface	   and	   protrude	  
approximately	   1	   mm	   below	   the	   skull,	   theoretically	   resting	   on	   the	   cortical	   surface.	   	   Each	   cannula	   opening	   was	  
protected	  using	  a	  plastic	  cap	  that	  was	  removed	  prior	  to	  the	  injection.	  	  
	  	   12	  
latency	  period	  with	  remission	  gained	  after	  only	  two	  days.	  	  Therefore,	  a	  dose	  of	  2.5	  ng	  in	  1	  μL	  was	  
tested	  and	  this	  proved	  optimal.	  	  This	  final	  dose	  had	  a	  latent	  period	  of	  three	  to	  five	  days,	  with	  seizure	  
activity	   induced	   that	   did	   not	   exceed	   2%	   of	   the	   animal’s	   lifetime	   as	   per	   the	   project	   licence’s	  
limitations.	  	  	  
The	  dose	  that	  each	  animal	  received	  can	  be	  seen	  in	  Table	  2	  (see	  Results).	  	  1	  μL	  of	  2%	  BSA	  in	  
PBS	  with	  or	  without	  TeNT	  was	  stereotaxically	  injected	  into	  each	  animal’s	  ventral	  hippocampus	  using	  
a	  Hamilton	  syringe	  (25G,	  7001	  KH,	  Hamilton	  Company,	  US).	  	  For	  those	  animals	  with	  a	  cannula,	  the	  
syringe	  was	  lowered	  to	  the	  base	  of	  the	  cannula	  and	  then	  lowered	  to	  the	  target	  site	  (Table	  1)	  taking	  
into	  account	  the	  distance	  the	  cannula	  protruded	  into	  the	  cortex.	  	  Each	  injection	  was	  made	  using	  a	  
microinjection	  pump	  at	  200	  nL	  min-­‐1	  and	  left	   in	  situ	  for	  five	  minutes	  after	  the	  injection	  to	  prevent	  
backflow	   up	   the	   needle	   tract.	   	   The	   location	   of	   the	   injection	   site	  was	   confirmed	   by	   post-­‐mortem	  
microscopic	  inspection	  of	  the	  hippocampus	  and	  the	  surrounding	  structures.	  	  
In	  Vivo	  Recording	  	  
	   EEG	   and	   ECG	   data	   were	   recorded	   continuously,	   along	   with	   video,	   using	   two	   different	  
systems:	   one	   for	   each	   radiotelemeter	   type	   used.	   	   Two	   types	   of	  DSI	   radiotelemeter	   (F50-­‐EEE	   and	  
F20-­‐EET;	  Data	  Science	  International,	  US)	  were	  implanted	  with	  multi-­‐channel	  biopotential	  electrodes	  
into	  animals	  with	  signals	  acquired	  by	  a	  PhysioTel® Receiver	  (RPC-­‐1;	  Data	  Science	  International,	  US)	  
and	  digitised	  using	  a	  Data	  Exchange	  Matrix	  (Data	  Science	  International,	  US).	  	  Signals	  were	  visualised	  
using	  Dataquest A.R.T™	  software	  (v.4.3;	  Data	  Science	  International,	  US).	  	  Data	  were	  exported	  offline	  
into	  Spike2	  (v.7.08,	  Cambridge	  Electronic	  Design	  Ltd.,	  UK)	  for	  analysis.	  	  
	   Each	  TR	  implanted	  animal	  was	  implanted	  with	  dual	  biopotential	  telemeters	  (TR50BB;	  Millar	  
Instruments,	  US),	  with	  a	  sampling	  frequency	  of	  2	  kHz	  and	  housed	  in	  a	  non-­‐metallic	  cage	  on	  top	  of	  a	  
SmartPad	   (TR180;	   Millar	   Instruments,	   US).	   	   Recordings	   were	   digitised	   using	   a	   Power1401	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(Cambridge	   Electronic	   Design	   Ltd.,	   UK)	   at	   a	   sampling	   frequency	   of	   500	   Hz	   and	   stored	   in	   Spike2	  
format.	  	  
Data	  Analysis	  
Firstly,	  each	  animal’s	  seizure	  profile	  was	  analysed:	  the	  length	  of	  each	  seizure	  plotted	  against	  
the	  time	  of	  onset	  post	  injection.	  	  In	  order	  to	  complete	  the	  analysis	  within	  the	  required	  period,	  and	  
in	  order	  to	  observe	  the	  changes	  to	  the	  animal’s	  HR	  induced	  by	  repeated	  seizure,	  and	  allow	  analysis	  
over	  a	  longer	  period	  of	  time:	  one	  seizure	  was	  sampled	  from	  each	  of	  the	  four	  six-­‐hour	  recordings	  per	  
day.	  	  Each	  seizure	  was	  divided	  into	  three	  epochs:	  (1)	  300s	  Pre-­‐Ictal,	  (2)	  Ictal	  (length	  dependent	  on	  
seizure)	  and	  (3)	  300	  s	  Post-­‐Ictal.	  	  
Seizure	  Detection	  
	   Seizures	  were	   identified	  by	   rhythmic	  electrical	   activity	  exceeding	  0.5	  mV	   that	   lasted	  more	  
than	  20	  s	  with	  a	  frequency	  exceeding	  130	  Hz.	  	  Figure	  4	  shows	  four	  example	  seizures.	  	  The	  majority	  
of	  seizures	  analysed	  resembled	  Figure	  4C.	  	  
R-­‐Wave	  Detection	  and	  Heart	  Rate	  Extrapolation	  	  
An	  example	  ECG	  can	  be	  seen	  in	  Figure	  3.	  	  This	  shows	  the	  components	  of	  the	  ECG	  in	  the	  rat,	  
which	  differs	  from	  the	  human	  ECG	  in	  that	  it	  does	  not	  have	  a	  distinctive	  T-­‐Wave.	  	  The	  animal’s	  ECG	  
had	   to	  be	  processed	   in	   order	   create	   the	   animals	   heart	   rate,	  whereby	   each	  R-­‐wave	  was	  detected	  
using	  an	  Event	  Detection	  script	  in	  Spike2	  (courtesy	  of	  Steven	  Clifford,	  CED)	  that	  discriminated	  the	  R-­‐
wave	   from	   noise	   by	   a	   user-­‐determined	   threshold	   and	   converted	   each	   R-­‐wave	   into	   a	   time-­‐point.	  	  
However,	  this	  script	  produced	  many	  false	  negatives	  and	  false	  positives	  and	  so	  each	  epoch	  of	  ECG	  
analysed	  required	  manual	  verification	  with	  any	   inaccuracies	  rectified	  to	  the	  best	  of	   the	  analyser’s	  
ability.	   	   The	   animal’s	   heart	   rate	   can	   be	   calculated	   by	   the	   reciprocal	   of	   the	   intervals	   between	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adjacent	  R	  waves.	   	  The	   instantaneous	  frequency	   function	  in	  Spike2	  performed	  this	  calculation	  and	  
performed	   fitting	   process	   so	   that	   it	   could	   be	   sampled	   at	   a	   constant	   frequency	   of	   10	   Hz.	   	   The	  
resulting	  frequency	  was	  converted	  to	  beats	  per	  minute	  (bpm)	  by	  multiplying	  by	  60.	  	  	  
Each	  epoch	  was	  analysed	  so	  that	  each	  R-­‐R	   interval/heart	  rate	  was	  treated	  as	  a	  single	  data	  
point	   and	   a	   histogram	  was	   produced	   that	   represented	   the	   proportion	   of	   the	   heart	   rates	   in	   that	  
instantaneous	   frequency	  bin	   expressed	  as	  a	  percentage	  of	   the	   total	  number	  of	  data	  points.	   	   This	  
allowed	   the	  modal	   heart	   rate	   to	   be	   established,	   but	   also	   identify	   any	   bradycardia	   or	   tachycardia	  
present,	   as	   this	   would	   be	   represented	   by	   a	   shift	   in	   the	   distribution	   to	   lower	   or	   higher	   values	  
respectively.	  	  	  
	  
Statistical	  Analysis	  
Statistical	   analysis	   included	   general	   linearised	   model	   and	   one-­‐way	   ANOVA.	   	   All	   data	   was	  
expressed	  as	  either	  the	  mode	  -­‐	  in	  respect	  of	  the	  distribution	  analysis	  -­‐	  or	  mean	  ±	  standard	  error	  of	  
the	  mean.	  	  
	  
Figure	  3	  
An	  example	  ECG	  of	  the	  rat.	  	  Each	  wave	  corresponds	  to	  electrical	  activity	  in	  the	  heart.	  	  The	  P-­‐wave	  corresponds	  with	  atrial	  
depolarisation,	   the	  QRS	   complex	   ventricular	   depolarisation,	  and	   the	  T-­‐wave	   corresponds	   to	   ventricular	   repolarisation.	  	  
The	  rat	  ECG	  differs	  to	  a	  human	  ECG	  in	  that	  it	  does	  not	  have	  a	  distinct	  T-­‐wave.	  	  






Examples	  of	  seizures	  seen	  in	  this	  study.	  	  A	  number	  of	  objective	  criteria	  were	  used	  to	  identify	  seizures	  and	  discriminate	  
them	   from	  non-­‐epileptic	  EEG,	   including	  the	  morphology	  of	   the	  seizure	  and	  the	  magnitude	  of	  the	  activity.	   	  The	  onset	  
and	  termination	  of	  each	  seizure	  are	  marked	  by	  arrows,	  and	  are	  the	  same	  period	  is	  represented	  in	  Figure	  10	  and	  Figure	  
11	  as	  a	  red	  line.	  	  The	  majority	  of	  seizures	  seen	  in	  this	  study	  resemble	  C.	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Results	  
Seizures	  Observed	  	  
Repeated	  spontaneous	  seizures	  were	  seen	   in	   four	  of	   the	  six	  TeNT	   injected	  animals.	   	  These	  
seizures	   induced	   behavioural	   changes,	   such	   as	   hyperreactivity,	   as	  well	   as	   EEG	   changes.	   	   Seizures	  
caused	   EEG	   distortions	   such	   as	   those	   in	   Figure	   4,	   with	   rhythmic	   activity	   exceeding	   0.5	   mV	   in	  
amplitude,	   lasting	  an	  average	  of	  65	  ±	  1	  s	  for	  all	  seizures.	   	  Seizure	  began	  as	  behaviour	  arrest,	  with	  
staring	  and	  sniffing	  automatisms,	  followed	  by	  unilateral	  or	  bilateral	  forelimb	  clonus,	  rearing,	  falling	  
and	   in	   two	  animals	   (JJ130404	  and	   JJ130703)	  wild	   running.	   	  No	  status	  epilepticus	  was	  observed	  at	  
any	  point.	  	  
With	   EEG	   electrodes	   placed	   into	   the	   neocortex,	   partial	   seizures	   or	   epileptic	   activity	   that	  
failed	   to	   reach	   the	   cortex	   may	   not	   have	   been	   observed.	   	   This	   may	   have	   been	   the	   case	   with	  
JJ130703,	   as	   it	   exhibited	  wild	   running	   that	   could	   have	   been	   a	   product	   of	   a	   partial	   seizure	   in	   the	  
ventral	  limbic	  structures	  or	  the	  brainstem,	  however	  the	  EEG	  recording	  could	  not	  corroborate	  this.	  	  
Animal	  Information	  
Table	  2	  shows	  a	  summary	  of	  the	  eight	  animals	  used	  in	  this	  study.	  	  The	  seizure	  profiles	  of	  the	  
four	  animals	  are	  shown	  in	  Figure	  5.	  	  JJ130404	  (Figure	  5A)	  was	  implanted	  with	  a	  DSI	  radiotelemeter	  
and	   injected	  with	  5	  ng	  of	  TeNT	   in	  1	  μl	  PBS/BSA.	   	  This	  animal	  experienced	  seizures	   two	  days	  post	  
injection	  but	  had	  to	  be	  killed	  on	  the	  third	  day	  (indicated	  by	  the	  dotted	  red	  line,	  Figure	  5A)	  as	  there	  
was	   a	   technical	   fault	   with	   the	   radiotelemeter	   implanted.	   	   This	   animal	   also	   had	   Racine	   Scale	   5	  
seizures,	  average	  length	  70	  ±	  8	  s.	  	  It	  also	  exhibited	  wild	  running	  and	  had	  a	  very	  short	  latency	  period,	  
which	   together	   suggested	   the	   ventral	   hippocampus	   could	   be	   more	   sensitive	   than	   the	   dorsal	   to	  
TeNT.	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JJ130411	  (Figure	  5B)	  was	  also	  implanted	  with	  a	  DSI	  radiotelemeter,	  but	  was	  injected	  with	  1	  
ng	   of	   TeNT	   in	   1	   μl	   PBS/BSA.	   	   This	   animal	   did	   not	   experience	   any	   seizures	   until	   nine	   days	   post	  
injection,	  when	  it	  experienced	  64	  seizure	  (average	  length	  81	  ±	  3	  s)	  but	  entered	  remission	  10	  days	  
post	   injection	   and	   did	   not	   experience	   another	   seizure,	  which	   showed	   the	   dose	  may	   be	   too	   low.	  	  
JJ130513	   (Figure	   5C)	   and	   JJ130521	   (Figure	   5D)	   were	   both	   injected	   with	   2.5	   ng	   of	   TeNT	   in	   1	   μl	  
PBS/BSA	   and	   experienced	   seizures	   four	   and	   three	   days	   afterwards	   respectively.	   	   Both	   animals	  
entered	   a	   period	   of	   quiescence	   after	   an	   initial	   episode	   of	   seizures;	   however,	   a	   technical	   issue	  
prevented	   data	   acquisition	   between	   days	   seven	   and	   nine	   post	   injection	   (indicated	   by	   shading	   in	  
Figure	  5C)	  and	  masked	  the	  extent	  of	  this	  quiescence	  for	  JJ130513.	  	  JJ130513	  had	  200	  seizures	  within	  
the	  first	  14	  days	  post	  injection,	  with	  an	  average	  length	  of	  57	  ±	  2	  s,	  and	  JJ130521	  had	  82	  seizures	  in	  
the	  same	  period,	  average	  length	  70	  ±	  3	  s.	  	  It	  was	  not	  possible	  to	  classify	  all	  seizures	  analysed	  due	  to	  
an	  absence	  of	  evidence	  from	  the	  video	  recording.	  
JJ130701	   and	   JJ130703	   were	   also	   injected	   with	   2.5	   ng	   of	   TeNT	   in	   1	   μl	   PBS/BSA	   while	  
JJ130702	  and	  JJ130704	  were	   the	  control	  animals.	   	   JJ130701,	   JJ130702	  and	  JJ130704	  opened	  their	  
abdominal	  wounds	  and	  had	  to	  be	  euthanised	  (11,	  six,	  and	  six	  days	  post	   injection	  respectively),	  as	  







TeNT	  Dose	  	  










JJ130404	   268	   DSI	   5	   13	   N/A	   70	  ±	  8	  
JJ130411	   337	   DSI	   1	   64	   N/A	   81	  ±	  3	  
JJ130513	   210	   TR	   2.5	   200	   18	   57	  ±	  2	  
JJ130521	   294	   TR	   2.5	   82	   7	   70	  ±	  3	  
JJ130701	   230	   TR	   2.5	   -­‐	   -­‐	   -­‐	  
JJ130702	   231	   TR	   Control	   N/A	   N/A	   N/A	  
JJ130703	   260	   TR	   2.5	   -­‐	   -­‐	   -­‐	  
JJ130704	   250	   TR	   Control	   N/A	   N/A	   N/A	  
Table	  2	  
A	  summary	  of	  each	  animal	  used	  in	  this	  study.	  	  The	  seizure	  activity	  of	  JJ130701	  and	  JJ130703	  could	  not	  be	  established	  
due	  to	  technical	  issues.	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JJ130702	   also	   chewed	   through	   the	   electrode	   wires	   three	   and	   seven	   days	   post	   injection,	  
respectively.	   	   JJ130701	  was	   not	   observed	   seizing	   during	   the	   day	   and	  without	   EEG	   recording,	   any	  
nocturnal	  seizure	  activity	  could	  not	  be	  confirmed.	  	  JJ130703	  exhibited	  epileptic	  behaviour,	  namely	  
hyperreactivity	   and	   wild	   running.	   	   However,	   its	   EEG	   recording	   could	   not	   corroborate	   the	   wild	  
running	  as	  a	  typical	  seizure,	  as	  depicted	  in	  Figure	  4	  (see	  Methods).	  	  Furthermore,	  the	  animal	  had	  to	  
be	  euthanised	  nine	  days	  post	  injection	  on	  welfare	  grounds.	  	  	  
	   Due	  to	  the	  above,	  the	  data	  from	  JJ130701	  and	  JJ130703	  were	  excluded	  the	  analysis	  and	  only	  
six	  days	  were	  included	  in	  the	  control	  data.	  	  	  
The	  Normal	  Heart	  Rate	  	  
	   The	   heart	   rate	   of	   each	   control	   animal,	   derived	   from	   the	   ECG	   R-­‐R	   interval,	   was	   analysed.	  	  
Firstly,	   each	  epoch	  of	   extrapolated	  R-­‐R	   intervals	   (Figure	  6A)	  was	   analysed	   so	   that	   the	  number	  of	  
times	  a	  heart	  rate	  falls	  into	  a	  specific	  10	  bpm	  bin	  (from	  50-­‐900	  bpm)	  was	  counted	  and	  plotted	  as	  a	  
frequency.	  	  Overall,	  the	  modal	  heart	  rate	  for	  both	  control	  animals	  was	  360	  bpm,	  with	  a	  range	  of	  270	  
to	  540	  bpm.	  	  Figure	  6A	  shows	  an	  example	  of	  the	  variation	  in	  the	  heart	  rate	  of	  JJ130704	  over	  a	  six-­‐
hour	   period	   (Figure	   6A),	  where	   the	   heart	   rate	   oscillates	   between	   300	   and	   500	   bpm.	   	   The	  modal	  
heart	   rate	   of	   this	   epoch	   was	   390	   bpm,	   as	   shown	   by	   Figure	   6B.	   	   Figure	   6C	   shows	   the	   variation	  
between	   the	   two	   animals	   over	   the	   four	   six	   hour	   epochs	   on	   each	   of	   the	   six	   days	   analysed.	   	   Both	  
animals’	  heart	  rates	  distributed	  around	  400	  bpm	  with	  little	  variation	  day-­‐to-­‐day.	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The	  Effect	  of	  Seizure	  on	  Heart	  Rate	  
	   Across	   all	   four	   animals,	   bradycardia	   was	   observed	   during	   68	   (89%)	   of	   the	   76	   seizures	  
analysed.	  	  An	  example	  of	  this	  ictal	  bradycardia	  is	  depicted	  in	  Figure	  7.	  	  The	  average	  decrease	  across	  
these	  68	  seizures	  was	  266	  ±	  12	  bpm,	  with	  this	  bradycardia	  lasting	  38	  ±	  2	  s.	  	  The	  seizure	  in	  Figure	  7	  
elicited	  a	  decrease	  of	  261	  bpm,	   from	  355	  bpm	  to	  94	  bpm,	   lasting	  23	  s.	   	  The	  quantification	  of	   the	  
bradycardia	  for	  each	  animal	  can	  be	  seen	  below	  (Table	  3).	  	  
	  
Figure	  5	  
Seizure	  Profile	  of	  four	  of	  the	  TeNT	  injected	  animals.	  	  A)	  The	  two	  days	  of	  seizures	  recorded	  from	  JJ130404	  before	  the	  
DSI	  radiotelemeter	  used	  failed	  -­‐	  indicated	  by	  the	  red	  dotted	  line.	  	  B)	  The	  seizures	  experienced	  by	  JJ130411,	  which	  was	  
injected	  with	  1	  ng	  of	  TeNT	  in	  1	  μl	  PBS.	  	  This	  animal	  experienced	  64	  seizures	  on	  Days	  9	  and	  10	  post	  injection,	  before	  
experiencing	   remission.	   	   C	   and	   D)	   The	   seizures	   experienced	   by	   JJ130513	   and	   JJ130521	   respectively,	   with	   the	   red	  
shaded	  portion	  of	  C	  depicting	  a	  period	  of	  missing	  data	  caused	  by	  technical	  issues.	  	  JJ130521	  experienced	  12	  seizures	  
on	  Day	  3	  and	  4	  before	  entering	  a	  period	  of	  quiescence	  until	  Day	  9.	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Post-­‐ictal	  tachycardia	  was	  observed	   in	  71	  of	  the	  76	  (93%)	  seizures	  analysed,	  also	  shown	  in	  
Figure	  7.	   	  The	  heart	  rate	   increased	  post-­‐ictally	  by	  a	  mean	  of	  129	  ±	  7	  bpm	  across	  all	  animals,	  with	  
each	   animal’s	   average	   tachycardia	   shown	   in	   Table	   3.	   	   The	   duration	   of	   this	   post-­‐ictal	   tachycardia	  
varied,	  lasting	  a	  mean	  863	  ±	  87	  s.	  	  
	  
Figure	  6	  
The	   variability	   in	   the	   two	   control	   animals’	   HR.	   	  A)	   An	   example	  
instantaneous	  HR	  of	  JJ130704,	  between	  midday	  and	  6	  pm,	  2	  days	  
post	   injection.	   	   The	   R-­‐wave	  was	   detected	   and	   interpolated	   into	  
the	  heart	   rate	  by	  using	   the	   instantaneous	  frequency	   function	   in	  
Spike2,	  and	  displayed	  as	  dots.	  	  B)	  The	  proportion	  of	  heart	  rates	  at	  
a	   specific	   instantaneous	   frequency	   for	   the	   6-­‐hour	   epoch	   in	   A,	  
with	  a	  mode	  of	  390	  bpm	  and	  a	  range	  of	  320	  to	  500	  bpm.	  	  C)	  The	  
mean	   heart	   rate	   (thick	   line),	   and	   the	   SEM	   (thin	   lines)	   for	   each	  
animal,	  on	  days	  1,	  2,	  4	  and	  6;	   showing	   the	  variation	  over	   the	  6	  
days.	  	  




Bradycardia	  and	  Arrhythmia	  
The	   bradycardia	   shown	   in	   Figure	   7	   was	   caused	   by	   two	   phenomena.	   	   Firstly,	   there	   was	   a	  
genuine	   (sinus)	  bradycardia	  caused	  by	   the	  R-­‐R	   interval	   increasing.	   	  Secondly,	   the	  bradycardia	  was	  
caused	  by	  arrhythmias	  –	  namely	  missed	  beats.	   	  An	  example	  of	  missed	  beats	   induced	  by	  a	  seizure	  
can	  be	  seen	   in	  Figure	  8.	   	  Two	  missed	  beats,	  with	  absent	  p-­‐waves,	  can	  clearly	  be	  seen	   in	   the	   ictal	  
epoch,	   when	   compared	   to	   the	   pre-­‐	   and	   post-­‐ictal	   ECG	   traces	   (Figure	   8D).	   	   Missed	   beats	   were	  
observed	   in	   45	   (59%)	   of	   the	   76	   seizures	   analysed.	   	   Less	   frequently,	   other	   arrhythmias	   were	  
	  
Figure	  7	  
A	  representative	  example	  showing	  the	  effect	  of	  epileptic	  seizure	  on	  the	  heart	  rate.	  	  This	  seizure,	  taken	  from	  JJ130513,	  



































JJ130404	   332	  ±	  56	   -­‐	  144	  ±	  44	   0.68	  ±	  0.10	   47	  ±	  6	   564	  ±	  28	   088	  ±	  16	   1.19	  ±	  0.04	   0397	  ±	  182	  	  
JJ130411	   182	  ±	  34	   -­‐	  206	  ±	  26	   0.46	  ±	  0.07	   49	  ±	  6	   535	  ±	  17	   147	  ±	  23	   1.40	  ±	  0.07	   0500	  ±	  241	  
JJ130513	   111	  +	  10	   -­‐	  326	  ±	  12	   0.25	  ±	  0.02	   35	  ±	  2	   533	  ±	  06	   096	  ±	  09	   1.23	  ±	  0.02	   0857	  ±	  156	  
JJ130521	   154	  ±	  21	   -­‐	  222	  ±	  19	   0.40	  ±	  0.05	   35	  ±	  1	   541	  ±	  12	   169	  ±	  11	   1.46	  	  	  0.03	   1078	  ±	  115	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  
All	  
Seizures	   152	  ±	  13	   -­‐	  266	  ±	  12	   0.37	  ±	  0.03	   38	  ±	  2	   541	  ±	  06	   129	  ±	  7	   1.33	  ±	  0.02	   0863	  ±	  087	  
Table	  3	  
A	   summary	   of	   the	   changes	   in	   heart	   rate	   induced	   by	   seizure.	   	   68	   seizures	   induced	   bradycardia,	   with	   the	   average	  
magnitude	  for	  each	  animal	  displayed.	  	  All	  76	  seizures	  induced	  tachycardia,	  the	  data	  for	  which	  can	  also	  be	  seen.	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observed	  (Figure	  9):	  including	  ventricular	  premature	  depolarisation	  indicated	  by	  arrows	  (during	  22	  





The	  Effect	  of	  Progressive	  Seizure	  
JJ130404,	   JJ130411	   and	   JJ130513	   showed	   ictal	   bradycardia	   for	   all	   seizures.	   	   However,	  
JJ130521	  initially	  experienced	  ictal	  tachycardia	  during	  day	  three	  and	  four	  post	  injection.	  	  After	  the	  
four	  day	  period	  of	  quiescence	  (Figure	  5D),	   it	  experienced	  ictal	  bradycardia.	   	  This	  progression	  from	  
tachycardia	  to	  bradycardia	  can	  be	  seen	  in	  Figure	  11.	  	  Both	  JJ130513	  (Figure	  10)	  and	  JJ130521	  (Figure	  
11)	   show	   a	   shift	   in	   their	   heart	   rate’s	   distribution	   induced	   by	   seizure	   (red	   line).	   	   Each	   of	   the	  
histograms	  were	  normalised	  to	  the	  total	  number	  of	  heart	  beats	  for	  the	  epoch	  analysed.	  	  
	  
Figure	  8	  
An	  example	  of	  seizure	  induced	  missed	  beats	  and	  the	  effect	  on	  the	  HR,	  with	  the	  pre-­‐	  and	  post-­‐ictal	  periods	   included	  
for	  comparison.	  	  Each	  image	  is	  a	  magnification	  of	  the	  previous,	  from	  a	  45	  s	  epoch	  (A)	  to	  a	  2	  s	  epoch	  (D).	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The	  example	  seizures	   in	  Figure	  10	  and	  Figure	  11	  show	  that	  seizures	   induced	  a	  decrease	   in	  
the	  animals’	  heart	  rate,	  and	  a	  shift	  in	  the	  ictal	  distribution,	  with	  the	  tails	  over	  the	  lower	  heart	  rates	  
signifying	   the	   bradycardia.	   	   Furthermore,	   this	   bradycardia	   is	   superimposed	   onto	   a	   tachycardia,	  
which	  continues	  into	  the	  post-­‐ictal	  period	  (blue	  line),	  and	  is	  the	  cause	  of	  the	  shift	  to	  higher	  rates	  of	  
the	  modal	  heart	  rate	  in	  many	  of	  the	  examples	  shown.	  	  Finally,	  it	  can	  be	  seen	  that	  the	  pre-­‐ictal	  state	  
(black	  line)	  varies	  slightly	  for	  JJ130513	  (Figure	  10)	  and	  is	  more	  stable	  in	  JJ130521	  (Figure	  11).	  	  For	  all	  
seizures	   analysed	   the	  average	  pre-­‐ictal	   heart	   rate	  was	  412	  ±	  7	  bpm.	   	   In	   JJ130521,	   the	  heart	   rate	  
increases	   before	   seizure	   onset	   (Figure	   11A-­‐F).	   	   This	   could	   be	   a	   consequence	   of	   recording	   some	  
	  
Figure	  9	  
Examples	   of	   the	   arrhythmias	   seen	   in	   this	   study.	   	   All	   three	   panels	   show	   premature	   ventricular	   depolarisations	   –	  
indicated	  by	  the	  arrows	  -­‐	  with	  C	  showing	  evidence	  of	  ventricular	  fibrillation-­‐	  identified	  by	  the	  dotted	  line.	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distance	  from	  the	  seizure	  onset	  zone	  and	  not	  being	  able	  to	  detect	  the	  beginning	  of	  the	  seizure.	  	  
When	  displaying	  all	  seizures	  together	  (Figure	  12),	  it	  can	  be	  seen	  that	  the	  pre-­‐ictal	  heart	  rate	  
is	  very	  similar	  to	  the	  control	  animals’	  heart	  rate	  (red	  line,	  Figure	  12)	  whereas	  there	  is	  a	  shift	  to	  the	  
higher	  heart	  rates	  for	  both	  the	  ictal	  and	  post-­‐ictal	  periods.	  	  This	  corroborates	  the	  individual	  seizure	  
data,	   showing	   a	   general	   shift	   to	   the	   higher	   heart	   rates	   induced	   by	   seizure.	   	   During	   seizures,	   the	  
bradycardia	  causes	   the	   tail	  over	   the	   lower	  heart	   rates,	  with	   the	  discontinuous	  appearance	  of	   this	  
tail	  reflecting	  the	  missed	  beats.	  	  
In	   order	   to	   explore	   any	   heart	   rate	   difference	   between	   the	   three	   epochs	   and	   the	   four	  
animals,	   as	   well	   as	   any	   progressive	   change	   in	   heart	   rate	   with	   successive	   seizures,	   a	   general	  
linearised	  model	  was	  used.	  	  This	  model	  assumes	  factors	  (Animal	  and	  Epoch)	  and	  covariates	  (Seizure	  
number)	   have	   a	   linear	   relationship	   with	   the	   dependent	   variable	   (heart	   rate).	   	   Each	   term	   in	   the	  
model	  and	  the	  model	  as	  a	  whole	  (see	  Sources	  column,	  Table	  4)	  is	  tested	  for	  its	  ability	  to	  account	  for	  
the	  variation	   in	  the	  heart	  rate.	   	   If	   the	  significance	  value	  calculated	   is	  below	  α	  (0.05)	   in	  this	  study,	  
then	  this	  variable	  has	  a	  significant	  effect	  on	  the	  heart	  rate.	   	  The	  result	  of	  this	  analysis	   is	  shown	  in	  
Table	  4.	  	  
	  
	   Therefore,	  each	  variable	  assessed	  by	   this	  model	  has	  a	   significant	  effect	  on	   the	  heart	   rate.	  	  





Square	   F	  Statistic	   Sig.	  
Corrected	  Model	   05994804.37	   012	   0499567.03	   0113.91	   P	  <	  0.001	  
Intercept	   04859435.20	   001	   4859435.20	   1108.05	   P	  <	  0.001	  
SeizureNo	   00018072.54	   001	   0018072.54	   0004.12	   P	  =	  0.044	  
AnimalNo	   00077188.98	   003	   0025729.66	   0005.87	   P	  <	  0.001	  
Period	   03108288.61	   002	   1554144.31	   0354.38	   P	  <	  0.001	  
AnimalNo	  *	  Period	   00216117.95	   006	   0036019.66	   0008.21	   P	  <	  0.001	  
Error	   00925357.19	   211	   0004385.58	   	   	  	  
Total	   38161196.00	   224	   	   	   	  
Corrected	  Total	   06920161.55	   223	   	   	   	  
Table	  4	  
The	  result	  of	  the	  general	  linearised	  model	  used	  to	  assess	  the	  ability	  of	  each	  variable	  (Sources	  column)	  to	  account	  for	  
the	  variability	  observed	  in	  heart	  rate.	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There	  is	  a	  significant	  effect	  of	  the	  three	  epochs	  analysed	  (“Period”:	  F	  (2,	  211)	  =	  354.38,	  P	  <	  0.001),	  a	  
significant	  effect	  of	  the	  four	  animals	  (“Animal	  No”:	  F	  (3,	  211)	  =	  5.87,	  P<0.001)	  and	  also	  a	  significant	  
effect	   of	   repeated	   seizure	   (“Seizure	  No”:	   F	   (1,211)	   =	   4.121,	   P	   =	   0.004),	   indicating	   that	   successive	  
seizure	  has	  an	  effect	  on	  the	  animals’	  heart	  rate.	  	  
In	   order	   to	   explore	   the	   change	   in	   heart	   rate	   in	   the	   three	   epochs,	   a	   one-­‐way	  ANOVA	  was	  
performed	  with	  a	  more	  stringent	  α-­‐level	  used	  (0.01)	  to	  account	  for	  the	  fact	  that	  multiple	  tests	  have	  
been	  used.	  	  A	  significant	  difference	  between	  the	  heart	  rates	  in	  all	  three	  epochs	  (pre-­‐ictal,	  ictal	  and	  
post-­‐ictal)	  was	  observed	  in	  three	  of	  the	  four	  animals:	  JJ130411,	  JJ30513	  and	  JJ130521	  (Table	  5	  and	  
Table	  6).	  	  The	  heart	  rate	  of	  JJ130404	  in	  the	  pre-­‐ictal	  period	  was	  not	  significantly	  different	  from	  the	  
ictal	   or	   post-­‐ictal	   heart	   rates,	   with	   significance	   observed	   between	   the	   ictal	   and	   post-­‐ictal	   heart	  
rates.	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Figure	  10	  
The	  effect	  of	  seizure	  on	  JJ130513’s	  HR	  four	  (A),	  six	  (B),	  nine	  (C),	  10	  (D),	  12	  (E)	  and	  14	  (F)	  days	  post	   injection.	  	  Seizure	  (red	  
lines)	  induces	  a	  decrease	  from	  the	  Pre-­‐ictal	  HR	  (black	  lines)	  with	  many	  seizures	  having	  an	  elevated	  post-­‐ictal	  HR	  (blue	  lines).	  	  
The	  bradycardia	  is	  apparent	  in	  the	  histograms	  (right	  panel)	  which	  show	  a	  long	  tail	  extending	  over	  the	  lower	  heart	  rates.	  	  




The	  effect	  of	  seizure	  on	  JJ130521’s	  HR	  four	  (A),	  10	  (B),	  11	  (C),	  12	  (D),	  13	  (E)	  and	  14	  (F)	  days	  post	  injection.	  	  Initially,	  
the	  seizures	  (red	   line)	  induced	  tachycardia	   (A),	  however	  after	  the	  4	  day	  period	  absent	  of	  seizures,	   ictal	  bradycardia	  
was	  present	  (B-­‐F).	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Figure	  12	  
The	  distribution	  of	  the	  heart	  rates	  for	  all	  seizures	  analysed,	  for	  the	  pre-­‐ictal,	  ictal	  and	  post-­‐ictal	  periods,	  the	  red	  line	  
denotes	  the	  average	  distribution	  of	  the	  heart	  rates	  of	  both	  the	  control	  animals.	  	  There	  is	  a	  shift	  in	  the	  distribution	  to	  
the	  higher	  heart	  rates	  induced	  by	  seizure.	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220016.58	   2	   110008.29	   8.940	   P	  =	  0.002	  
Within	  
Groups	  
258393.38	   21	   12304.45	   	   	  




503038.08	   2	   251519.04	   53.630	   P	  <	  0.001	  
Within	  
Groups	  
98479.88	   21	   4689.52	   	   	  




3116697.90	   2	   1558348.95	   727.190	   P	  <	  0.001	  
Within	  
Groups	  
197153.32	   92	   2142.97	   	   	  




2362102.17	   2	   1181051.08	   203.500	   P	  <	  0.001	  
Within	  
Groups	  
470099.39	   81	   5803.70	   	   	  
Total	   2832201.56	   83	   	   	   	  
Table	  5	  
The	  results	  of	  the	  one-­‐way	  ANOVA	  assessing	  the	  variability	  within	  each	  animal’s	  heart	  rate	  during	  the	  pre-­‐ictal,	  ictal	  and	  
post	  ictal	  periods.	  	  A	  significant	  difference	  was	  observed	  in	  each	  animal,	  and	  a	  post-­‐hoc	  Bonferroni	  multiple	  comparisons	  
test	  (Table	  6)	  was	  performed	  to	  identify	  where	  this	  significance	  arises.	  	  
Dependent	  Variable	   Mean	  Difference	   Std.	  Error	   Sig	  
JJ130404	  
Pre-­‐Ictal	  
Ictal	   144.38	   55.46	   P	  =	  0.05	  
Post-­‐Ictal	   -­‐87.88	   55.46	   P	  =	  0.38	  
Ictal	  
Pre-­‐Ictal	   -­‐144.38	   55.46	   P	  =	  0.05	  
Post-­‐Ictal	   -­‐232.25	   55.46	   P	  <	  0.001	  
Post-­‐Ictal	  
Pre-­‐Ictal	   87.88	   55.46	   P	  =	  0.38	  
Ictal	   232.25	   55.46	   P	  <	  0.001	  
JJ130411	  
Pre-­‐Ictal	  
Ictal	   205.88	   34.24	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐147.13	   34.24	   P	  <	  0.001	  
Ictal	  
Pre-­‐Ictal	   205.88	   34.24	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐353.00	   34.24	   P	  <	  0.001	  
Post-­‐Ictal	  
Pre-­‐Ictal	   147.13	   34.24	   P	  <	  0.001	  
Ictal	   353.00	   34.24	   P	  <	  0.001	  
JJ130513	  
Pre-­‐Ictal	  
Ictal	   324.51	   11.67	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐97.33	   11.67	   P	  <	  0.001	  
Ictal	  
Pre-­‐Ictal	   324.51	   11.67	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐421.84	   11.57	   P	  <	  0.001	  
Post-­‐Ictal	  
Pre-­‐Ictal	   97.33	   11.67	   P	  <	  0.001	  
Ictal	   421.84	   11.57	   P	  <	  0.001	  
JJ130521	  
Pre-­‐Ictal	  
Ictal	   239.50	   20.36	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐169.25	   20.36	   P	  <	  0.001	  
Ictal	  
Pre-­‐Ictal	   -­‐239.50	   20.36	   P	  <	  0.001	  
Post-­‐Ictal	   -­‐408.75	   20.36	   P	  <	  0.001	  
Post-­‐Ictal	  
Pre-­‐Ictal	   169.25	   20.36	   P	  <	  0.001	  
Ictal	   408.75	   20.36	   P	  <	  0.001	  
Table	  6	  
The	  result	  of	  the	  post-­‐hoc	  Bonferroni	  multiple	  comparison	  tests.	  	  A	  significant	  difference	  (α=0.01)	  was	  observed	  between	  
all	  three	  epochs	  (pre-­‐ictal,	   ictal	  and	  ictal)	  analysed	  for	  JJ130411,	  JJ130513,	  and	  JJ130521.	   	  A	  significant	  difference	  was	  
only	  observed	  between	  the	  Ictal	  and	  post-­‐ictal	  heart	  rates	  for	  JJ130404.	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Discussion	  	  
This	  study	  aimed	  to	  explore	  the	  effect	  of	  seizure	  on	  the	  cardiovascular	  system,	  highlighting	  
any	   pathological	   change	   in	   order	   to	   gain	   insight	   into	   the	   processes	   that	   underpin	   SUDEP.	   	   By	  
implanting	   eight	   rats	  with	   radiotelemeters	   and	   continuously	   recording	   their	   EEG	   and	   ECG,	   it	  was	  
possible	  to	  observe	  the	  long-­‐term	  effect	  of	  seizure	  on	  the	  animal.	  	  	  
The	  major	   finding	  of	   this	   study	  was	   the	   autonomic	  dysfunction	   induced	  by	   seizure,	  which	  
manifest	  as	   ictal	  bradycardia	  and	   ictal	   tachycardia.	   	   Ictal	  bradycardia	  was	  observed	   in	  68	  (89%)	  of	  
the	  76	  seizures	  analysed	  across	  all	  four	  animal,	  with	  a	  mean	  ictal	  heart	  rate	  of	  152	  ±	  13	  bpm	  across	  
all	  seizures.	  	  This	  finding	  supports	  previous	  work	  in	  this	  lab,	  which	  observed	  ictal	  bradycardia	  after	  
electrical	   stimulation	   the	  dorsal	   and	  ventral	  hippocampus	  as	  a	  model	  of	  epileptic	   seizure	   (Vivian-­‐
Griffiths,	  2012).	  	  Furthermore,	  it	  corroborates	  reports	  of	  ictal	  bradycardia	  observed	  in	  other	  animal	  
models	  of	  epilepsy	  (Hotta	  et	  al.,	  2009,	  Mameli	  et	  al.,	  1993)	  and	  in	  human	  patients	  (Devinsky	  et	  al.,	  
1997;	  Nashef	  et	  al.,	  1996;	  Nei	  et	  al.,	  2000;	  So	  et	  al.,	  2000;	  Tinuper	  et	  al.,	  2001;	  Zijlmans	  et	  al.,	  2002).	  	  	  
Post-­‐ictal	   tachycardia	   was	   also	   observed,	   with	   a	   mean	   heart	   rate	   of	   541	   ±	   6	   bpm	   that	  
persisted	   for	  863	  ±	  87	  s.	   	  This	   finding	  supports	   studies	   showing	   ictal	  and	  post	   ictal	   tachycardia	   in	  
animal	  models	  (Damasceno	  et	  al.,	  2013)	  and	  humans	  (Leutmezer	  et	  al.,	  2003;	  Nashef	  et	  al.,	  1996;	  
Opherk	  et	  al.,	  2002;	  Tigaran	  et	  al.,	  2003;	  Zijlmans	  et	  al.,	  2002).	  	  Indeed,	  this	  study	  supports	  Nashef	  
et	   al.	   (1996)	   and	   Zijlmans	   et	   al.	   (2002),	   who	   had	   shown	   both	   seizure-­‐induced	   bradycardia	   and	  
tachycardia,	   with	   this	   period	   of	   bradycardia	   observed	   to	   be	   superimposed	   onto	   a	   post-­‐ictal	  
tachycardia	  in	  some	  of	  the	  seizures	  analysed	  in	  this	  study	  (Figure	  11B,	  C,	  F).	  	  	  
Furthermore,	  the	  arrhythmias	  observed	   in	  this	  study	  (premature	  ventricular	  depolarisation	  
and	   ventricular	   fibrillation)	   have	   also	   been	   observed	   in	   animal	   (Mameli	   et	   al.,	   1993)	   and	   human	  
studies	  (Nei	  et	  al.,	  2000;	  Opherk	  et	  al.,	  2002;	  Zijlmans	  et	  al.,	  2002).	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Origin	  of	  Bradycardia	  	  
In	  this	  study,	  1-­‐5	  ng	  of	  TeNT	  in	  1	  μl	  of	  PBS/BSA	  was	  stereotaxically	  injected	  into	  the	  ventral	  
hippocampus	  in	  order	  to	  model	  TLE.	  	  A	  prominent	  output	  of	  the	  hippocampus	  is	  the	  fornix,	  which	  
terminates	  in	  the	  hypothalamus	  (Bear	  et	  al.,	  2007).	  	  The	  hypothalamus	  has	  been	  shown	  to	  influence	  
the	   cardiovascular	   system	   when	   stimulated	   with	   penicillin	   G	   in	   rats	   (Mameli	   et	   al.,	   1993)	   and	  
electrically	  in	  rabbits	  (Gellman	  et	  al.,	  1981).	  	  The	  hypothalamus	  itself	  has	  projections	  to	  the	  medulla,	  
the	  location	  of	  the	  nucleus	  ambiguus	  (NA),	  the	  nucleus	  tractus	  solitarius	  (NTS)	  and	  the	  dorsal	  vagal	  
nucleus	   (DVN;	   Barrett	   et	   al.,	   2010),	   it	   was	   therefore	   envisaged	   that	   seizures	   with	   foci	   in	   the	  
hippocampus	  would	  have	  cardiovascular	  effects.	  	  	  
In	   normal	   conditions,	   three	   factors	   integrate	   and	   determine	   the	   heart	   rate:	   sympathetic	  
neurones,	  parasympathetic	  neurons	  and	  circulating	  adrenaline	  (Stanfield	  2011).	   	  Both	  branches	  of	  
the	  autonomic	  nervous	  system	  are	  constantly	  active	  and	  the	  balance	  between	  the	  two	  at	  a	  given	  
point	  results	  in	  the	  organism’s	  heart	  rate.	  	  
The	  heart	  rate	   is	  slowed	  by	   increased	  parasympathetic	  outflow	  from	  the	  NA,	  via	  the	  vagus	  
nerve.	   	   The	   slowing	   of	   the	   heart	   is	   induced	   by	   acetylcholine	   (ACh),	   released	   by	   post-­‐ganglionic	  
neurones,	  which	   slows	   the	   intrinsic	  pacemaker	  activity	  of	   the	   sinoatrial	  and	  atrioventricular	  node	  
(SAN,	   AVN).	   	   ACh	   binds	   to	   M2	   muscarinic	   receptors	   in	   the	   SAN.	   	   This	   leads	   to	   slowing	   of	   the	  
pacemaker	   potential	   by	   decreasing	   calcium	   and	   sodium	   currents,	   via	   Giβγ	   inhibition	   of	   T-­‐type	  
calcium	   channels	   and	   Funny	   channels	   respectively,	   and	   by	   increasing	   the	   potassium	   currents	   by	  
opening	  GIRK1	  channels	  (Richerson,	  2009;	  Stanfield,	  2011).	   	  The	  average	  ictal	  heart	  rate	  observed	  
across	  all	  76	  seizures,	  152	  ±	  13	  bpm,	  can	  be	  deemed	  bradycardic	  as	  it	   is	  pathologically	   lower	  than	  
the	  normal	  heart	  rate	  for	  the	  Wistar	  rat,	  that	  ranges	  between	  320	  and	  490	  bpm	  (Pass	  and	  Freeth,	  
1993).	  	  This	  bradycardia	  could	  be	  a	  result	  of	  seizure	  activity	  driving	  the	  hypothalamus,	  through	  the	  
fornix.	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There	   are,	   however,	   other	   explanations	   of	   the	   bradycardia	   observed.	   	   For	   example,	   an	  
increase	  in	  arterial	  blood	  pressure,	  as	  reported	  to	  occur	  in	  seizure	  (Damasceno	  et	  al.,	  2013)	  leads	  to	  
a	   reflexive	   decrease	   in	   heart	   rate	   (Barrett	   et	   al.,	   2010;	   Richerson,	   2009).	   	   Hypoxia,	   detected	   by	  
peripheral	   chemoreceptors	   (Marshall,	   1998),	   results	   in	   bradycardia	   and	   tachycardia.	   	   Lastly,	  
bradycardia	  can	  also	  be	  induced	  by	  increased	  intracranial	  pressure	  (Barrett	  et	  al.,	  2010;	  Fodstad	  et	  
al.,	  2006;	  Mangrum	  and	  DiMarco,	  2000),	  which	  itself	  has	  been	  associated	  with	  epilepsy	  and	  seizure	  
(Gabor	  et	  al.,	  1984;	  Minns	  and	  Brown,	  1978).	  	  These	  could	  be	  investigated	  as	  potential	  confounders	  
by	  recording	  arterial	  blood	  pressure,	  breathing	  rate,	  partial	  pressure	  of	  oxygen	  in	  the	  blood	  and	  by	  
using	  a	  pressure-­‐sensing	  electrode	  in	  the	  cranium.	  	  
Classifying	  Bradycardia	  	  
Sinus-­‐node	  dysfunction	   is	  a	   common	  source	  of	  bradycardia	  and	  can	  be	  caused	  by	   intrinsic	  
and	   extrinsic	   pathological	   influences	   (Mangrum	   and	   DiMarco,	   2000).	   	   There	   are	   many	   ECG	  
presentations	  of	  sinus-­‐node	  dysfunction	  (Figure	  13)	  that	  are	  caused	  by	  both	  intrinsic	  and	  extrinsic	  
factors.	   	   In	   this	   study,	   sinus	   bradycardia,	   sinus	   arrest	   and	   bradycardia-­‐tachycardia	   syndrome	  
(Mangrum	  and	  DiMarco,	  2000;	  Figure	  13)	  have	  been	  observed,	  as	  well	  as	  bradycardia	   induced	  by	  
missed	  beats.	   	   Sinus	  bradycardia	   is	  a	   result	  of	  depressed	  automaticity	  of	   the	  SAN,	  with	   increased	  
parasympathetic	   stimulation	   resulting	   in	   a	   slowing	   of	   the	   pacemaker	   potential	   (Richerson,	   2009;	  
Magrum	  and	  DiMarco,	  2000;	  Stanfield,	  2011),	  with	  sinus	  arrest	  due	  to	  failure	  of	  impulse	  conduction	  
from	  the	  SAN	  to	  the	  atrium.	  	  
The	   bradycardia	   observed	   in	   this	   study	   could	   be	   attributed	   to	   extrinsic	   influences	   on	   the	  
SAN,	   such	   as	   the	   aforementioned	   increased	   intracranial	   pressure	   and	   excessive	   parasympathetic	  
(vagal)	   tone	   (Barrett	   et	   al.,	   2010;	   Fodstad	   et	   al.,	   2006;	  Mangrum	   and	   DiMarco,	   2000).	   	   Intrinsic	  
causes,	  such	  as	  ischemia,	  could	  be	  confirmed	  with	  post-­‐mortem	  histological	  evaluation	  of	  the	  heart	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tissue.	   	   To	   that	   end,	   hearts	   were	   isolated	   post-­‐mortem	   and	   placed	   into	   paraformaldehyde	   for	  
processing	  by	  a	  collaborator	  who	  is	  currently	  setting	  up	  the	  protocols.	  	  However,	  as	  intrinsic	  causes	  
are	  chronic,	  it	  is	  unlikely	  that	  they	  are	  responsible	  for	  the	  transient	  bradycardia	  seen	  in	  this	  study.	  	  
	  
Ictal	  and	  Post-­‐Ictal	  Tachycardia	  
This	  study	  also	  showed	  ictal	  and	  post-­‐ictal	  tachycardia.	  	  Tachycardia	  is	  caused	  by	  activation	  
of	   the	   sympathetic	   nervous	   system.	   	   Noradrenalin	   activates	   β1-­‐adrenoceptors,	   leading	   to	   an	  
increase	   in	  sodium	  and	  calcium	  currents	   in	  the	  pacemaker	  cells,	  via	  protein	  kinase	  C	  activation	  of	  
the	  Funny	  channel	  and	  T-­‐type	  calcium	  channel,	  respectively	  (Barrett	  et	  al.,	  2010;	  Richerson,	  2009;	  
Stanfield,	  2011).	  	  This	  increase	  in	  sodium	  and	  calcium	  current	  increases	  the	  slope	  of	  the	  pacemaker	  
potential,	  in	  turn	  increasing	  the	  frequency	  of	  action	  potentials	  in	  the	  pacemaker	  cell.	  	  	  
The	  hormone	  adrenaline	  also	  causes	  the	  heart	  rate	  to	  increase	  via	  the	  same	  mechanism	  as	  
	  
Figure	  13	  
(Mangum	  and	  DiMarco,	   2000)	   	   Types	  of	   bradycardia	   induced	   by	   sinus	  node	   dysfunction.	   	   Sinus	  bradycardia,	   sinus	  
arrest	  and	  bradycardia-­‐tachycardia	  syndrome	  have	  been	  observed	  in	  this	  study.	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noradrenaline	   (see	   above).	   	   Adrenaline	   is	   released	   from	   the	   adrenal	   medulla	   as	   a	   result	   of	  
sympathetic	   stimulation	   via	   the	   preganglionic	   sympathetic	   neuron	   (Barrett	   et	   al.,	   2010).	   	   This	  
generally	  acts	  to	  reinforce	  the	  direct	  sympathetic	  stimulation	  of	  the	  SAN,	  and	  could	  be	  responsible	  
for	   the	   slow	   acceleration	   and	   long	   duration	   of	   the	   increase	   in	   heart	   rate	   seen	   in	   some	   seizures	  
(Figure	  11B,	  C,	  F).	  	  	  
The	   sympathetic	   and	   parasympathetic	   systems	   have	   opposite	   effects	   to	   each	   other.	  	  
Therefore,	   the	   possible	   explanations	   of	   the	   bradycardia	   above	   could	   also	   be	   used	   to	   explain	   the	  
tachycardia	  observed.	   	   If	   there	  was	  a	  decrease	   in	   the	  ABP,	   the	  baroreceptor	  reflex	  will	   initiate	  an	  
increase	   in	   the	   heart	   rate	   and	   likewise	   with	   a	   low	   partial	   pressure	   of	   oxygen	   and	   increased	  
breathing	   rate	   (Barrett	   et	   al.,	   2010;	   Richerson	   et	   al.,	   2009;	   Stanfield,	   2011).	   	   These	   causes	   of	  
tachycardia	   can	  be	   analysed	  by	   exploring	   the	   animal’s	   blood	  pressure	   and	  breathing	  pattern	   and	  
circulating	  noradrenalin	  levels	  during	  seizure.	  	  
Tachycardia	  is	  also	  induced	  by	  exercise.	  	  During	  the	  epileptic	  seizures	  induced	  by	  TeNT,	  the	  
animals	  experienced	  unilateral	  or	  bilateral	  forelimb	  clonus,	  rearing,	  falling	  and	  in	  two	  animals,	  wild	  
running.	   	   The	   enhanced	   muscle	   activity	   during	   these	   actions	   could	   result	   in	   tachycardia.	   	   Local	  
vasodilation	  brought	  about	  by	  changes	  to	  the	  chemistry	  of	  the	  interstitial	  fluid	  of	  the	  muscle	  would	  
induce	   a	   decrease	   in	   total	   peripheral	   resistance	   and	   fall	   in	   blood	   pressure,	   activating	   the	  
baroreceptor	   reflex	   (Boulpaep,	  2011).	   	   This	  needs	   to	  be	  explored	   further	   to	   identify	  whether	   the	  
tachycardia	   observed	   is	   a	   result	   of	   the	   increased	   muscle	   activity,	   from	   autonomic	   dysfunction	  
originating	  from	  the	  brain	  or	  from	  a	  combination	  of	  the	  two.	  	  
Ictal	  Bradycardia	  versus	  Ictal	  Tachycardia	  
Currently,	  no	  correlation	  between	  the	  epileptic	  foci	  and	  the	  ictal	  cardiovascular	  effects	  has	  
been	   established;	   it	   remains	   unclear	   as	   to	   why	   some	   seizures	   induce	   tachycardia,	   some	   induce	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bradycardia	   and	   others	   induce	   both	   (Sevcencu	   and	   Struijk,	   2010).	   	   The	   lateralisation	   hypothesis	  
proposes	   that	   seizures	  with	   a	   right-­‐sided	   epileptic	   focus	   induce	   tachycardia,	   and	   those	  with	   left-­‐
sided	   epileptic	   focus	   induces	   bradycardia.	   	   Evidence	   for	   this	   hypothesis,	   however,	   is	   limited	  
(Leutmezer	   et	   al.,	   2003;	   Mayer	   et	   al.,	   2004;	   Tinuper	   et	   al.,	   2001)	   with	   others	   not	   able	   to	  
substantiate	  such	  a	  theory	  (Nei	  et	  al.,	  2000;	  Opherk	  et	  al.,	  2002).	  	  
Several	   authors	   have	   suggested	   that	   instead	   of	   a	   simple	   right-­‐left	   dichotomy,	   seizure	  
discharges	   may	   activate	   sympathetic	   or	   parasympathetic	   centres,	   inducing	   tachycardia	   or	  
bradycardia	   (Leutmezer	   et	   al.,	   2003).	   	   Furthermore,	   it	   has	   been	   shown	   that	   parasympathetic	  
activation	   predominates	   during	   partial	   seizure	   (Devinksy,	   2004).	   	   To	   elucidate	   whether	   such	  
selective	   activation	   occurs,	   or	   whether	   the	   cardiovascular	   effect	   is	   determined	   by	   the	   type	   of	  
seizure,	  depth	  electrodes	  need	  to	  be	  placed	  into	  the	  hippocampus	  and	  potentially	  into	  the	  medulla,	  
to	  explore	  the	  activity	  of	   the	  NA	  (parasympathetic)	  and	  vasomotor	  area	  (sympathetic).	   	  However,	  
this	   could	  be	  difficult	  due	   to	   the	  anatomical	   location	  of	   these	   two	  structures	  within	   the	  medulla.	  	  
Therefore,	   the	  autonomic	  balance	  could	  be	  assessed	  with	  the	  non-­‐invasive	  measure	  of	  heart	   rate	  
variability	  (see	  below).	  	  
Cardioarrhythmias	  	  
Cardioarrhthymas	  are	  themselves	  linked	  to	  sudden	  death	  in	  the	  general	  population,	  with	  the	  
majority	   of	   sudden	   deaths	   caused	   by	   acute	   ventricular	   tachyarrhythmias	   (Huikuri	   et	   al.,	   2001).	  	  
Missed	   beats	  were	   observed	   in	   45	   (59%)	   of	   the	   76	   seizures	   analysed	  with	   ventricular	   premature	  
depolarisations	   (VPD;	  during	  22	   seizures;	  22%)	  and	  ventricular	   fibrillation	   (VF;	  during	  13	   seizures;	  
17%)	  also	  observed.	  	  These	  arrhythmias	  are	  consistent	  with	  those	  expected	  by	  excessive	  autonomic	  
activity	   observed	   in	   other	   studies	   (Nei	   et	   al.,	   2000;	   Opherk	   et	   al.,	   2000).	   	   These	   studies	   both	  
reported	  that	  generalised	  seizures	  in	  humans	  are	  a	  risk	  factor	  for	  ECG	  abnormalities.	   	  Generalised	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seizures	   have	   been	   identified	   as	   a	   risk	   factor	   for	   arrhythmia	   generation	   and	   as	   a	   risk	   factor	   for	  
SUDEP	  (Donner,	  2011;	  Nei	  et	  al.,	  2000).	  	  It	  was	  not	  possible	  to	  classify	  the	  seizures	  analysed	  in	  this	  
study	  as	  generalised	  or	  partial	  due	  to	  the	  nature	  of	  the	  EEG,	  and	  so,	  correlation	  between	  the	  ECG	  
abnormalities	  observed	  and	  the	  type	  of	  seizure	  could	  not	  be	  done.	  	  However,	  it	  could	  be	  assumed	  
that	  those	  observed	  seizures	  were	  secondary	  generalised,	  as	  partial	  seizures	  would	  stay	  close	  to	  the	  
ventral	   hippocampus,	   and	   perhaps	   circulate	   through	   the	   corresponding	   entorhinal	   cortex,	   and	  
would	  not	  be	  picked	  up	  by	  the	  EEG.	  	  Increasing	  the	  number	  of	  channels	  used	  to	  record	  the	  EEG	  and	  
also	   corroborating	   any	   epileptic	   activity	   with	   video	   files	   would	   aid	   in	   classifying	   seizures.	   	  While	  
video	  recording	  was	  attempted	  in	  this	  study,	  technical	  issues	  prevented	  its	  use.	  	  	  
Seizures	  could	  act	  through	  two	  mechanisms	  to	  produce	  the	  arrhythmias	  seen	  in	  this	  study.	  	  
Firstly,	   seizure-­‐induced	   increased	  autonomic	  activity	  may	  cause	  arrhythmia	  generation	   (Nei	  et	  al.,	  
2000)	  Secondly,	   repeated	  seizure	  may	  have	  a	  deteriorating	  effect	  on	  the	  heart;	   through	  repeated	  
autonomic	   stimulation,	   with	   myocardial	   fibrosis	   and	   myofibrillar	   degeneration	   caused	   by	  
catecholamine	  toxicity	  (Nei	  et	  al.,	  2000;	  Reichenbach	  and	  Benditt,	  1970).	  	  Both	  myocardial	  fibrosis	  
and	  myofibrillar	  degeneration	  have	  been	  shown	  in	  SUDEP	  patients	  (Earnest	  et	  al.,	  1992;	  Natelson	  et	  
al.,	   1998)	   and	   could	   cause	   arrhythmia	   generation	   (Nei	   et	   al.,	   2000).	   	   The	  presence	  of	  myocardial	  
fibrosis	   and	  myofibrillar	   degeneration	   in	   the	   animals	   used	   in	   this	   study	  will	   be	   explored	  by	   post-­‐
mortem	  histological	  investigation.	  	  	  
Previous	  studies	  have	  analysed	  the	  ECG	  waveform,	  analysing	  the	  QTc	  interval	  (Damasceno	  et	  
al.,	  2013;	  Nei	  et	  al.,	  2000)	  and	  the	  ST-­‐segment	  (Nei	  et	  al.,	  2000;	  Opherk	  et	  al.,	  2002;	  Zijlmans	  et	  al.,	  
2002).	   	   Both	   long	  QT	   syndrome	  and	   ST-­‐segment	  elevation	  have	  been	  associated	  with	   arrhythmia	  
generation	   and	   sudden	   death	   (Barrett	   et	   al.,	   2010).	   	   Therefore,	   such	   analysis	   could	   provide	  
information	  as	  to	  the	  origin	  of	  the	  arrhythmias	  observed	  in	  this	  study.	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Method	  Refinement	  	  	  
During	  this	  study,	  four	  of	  the	  animals	  (JJ130701,	  JJ130702,	  JJ130703	  and	  JJ130704)	  had	  to	  be	  
killed	  before	  the	  desired	  end-­‐point.	  	  This	  was	  due	  to	  each	  of	  them	  opening	  their	  abdominal	  wounds	  
and	  exposing	  the	  electrical	  wires.	  	  Under	  the	  terms	  of	  the	  Home	  Office	  Licence,	  each	  wound	  could	  
be	  repaired	  once,	  however	  each	  animal	  continued	  to	  open	  the	  wound.	  	  The	  other	  four	  animals	  did	  
not	  have	  any	  issues	  with	  their	  wounds.	  	  The	  major	  difference	  between	  the	  two	  sets	  of	  animals	  was	  
their	  size	  at	  the	  initial	  surgery	  (average	  weight:	  277	  g	  versus	  243	  g).	  	  The	  latter	  set	  of	  animals	  was	  
younger,	  and	  had	  thinner	  skin.	  	  This	  could	  have	  meant	  that	  they	  were	  irritated	  by	  the	  subcutaneous	  
wires	  and	  therefore	  scratched	  at	  their	  wounds	  more.	  	  Using	  larger	  rats	  in	  the	  future	  could	  avoid	  this	  
issue.	  	  
In	  order	  to	  avoid	  this	  in	  future	  experiments	  a	  number	  of	  refinements	  to	  the	  surgery	  can	  be	  
made	  in	  order	  to	  (1)	  avoid	  the	  animals	  opening	  their	  wounds	  and	  (2)	  prevent	  them	  from	  chewing	  on	  
the	   electrode	   wires.	   	   Firstly,	   smaller	   incisions	   could	   be	   made;	   therefore	   limiting	   the	   number	   of	  
sutures	  required	  and	  promoting	  the	  healing	  process.	   	  However,	   the	  size	  of	   the	  telemeter	  reduces	  
the	  extent	  to	  which	  this	  is	  practical.	  	  Secondly,	  surgical	  mesh	  could	  be	  placed	  subcutaneously	  over	  
the	  wires.	  	  This	  mesh	  is	  ordinarily	  used	  to	  repair	  hernias	  and	  therefore	  using	  it	  in	  this	  instance	  could	  
promote	  wound	  healing	  and	  limit	  the	  irritation	  caused.	  	  Thirdly,	  the	  electrode	  wires	  could	  be	  placed	  
away	  from	  the	  wound	  in	  order	  to	  reduce	  mechanical	  stress	  from	  the	  wire	  and	  prevent	  the	  animal	  
from	   chewing	   through	   the	   wires	   if	   it	   were	   to	   open	   its	   abdominal	   wound.	   	   Finally,	   each	   of	   the	  
younger	   set	   of	   animals	   was	   immediately	   housed	   with	   their	   companion	   rat,	   and	   this	   could	   have	  
contributed	  to	  the	  wound	  breakdown.	  	  Housing	  the	  animals	  alone	  for	  a	  short	  time	  after	  the	  surgery	  
may	   allow	   sufficient	   healing	   to	   occur	   before	   socialisation,	   preventing	   the	   wound	   breakdown	  
observed.	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Future	  Directions	  
There	  are	  a	  number	  of	  future	  investigations	  that	  need	  to	  be	  undertaken	  in	  order	  to	  elucidate	  
the	  mechanism	  by	  which	  the	  ictal	  bradycardia	  and	  tachycardia	  were	  produced.	  	  Firstly,	  performing	  
simultaneous	   recordings	   of	   the	   EEG,	   ECG,	   blood	   pressure	   and	   breathing	   rate	   will	   provide	  
information	  of	  the	  origin	  of	  the	  change	  in	  heart	  rate.	  	  By	  implanting	  EMG	  electrodes	  to	  record	  the	  
breathing	  rate,	  it	  could	  also	  be	  possible	  to	  identify	  and	  remove	  EMG	  artefacts	  from	  ECG	  recording.	  	  
However,	  in	  order	  for	  all	  of	  these	  parameters	  to	  be	  recorded	  simultaneously,	  a	  more	  sophisticated	  
radiotelemeter	  system	  would	  need	  to	  be	  employed.	   	  The	  DSI	  system	  has	  the	  ability	  to	  have	  more	  
channels,	  whereas	  the	  TR	  system	  does	  not,	  however	  the	  sampling	  frequency	  is	  comparably	  low	  (50-­‐
100	  Hz)	  to	  the	  TR	  system	  (1000	  Hz)	  and	  does	  not	  give	  the	  resolution	  required	  to	  explore	  the	  subtle	  
changes	   in	   the	   ECG	   waveform,	   such	   as	   QTc	   interval	   and	   ST	   segment,	   which	   are	   required	   for	  
arrhythmia	  analysis.	  	  
Autonomic	   tone	   could	   be	   analysed	   via	   heart	   rate	   variability.	   	   This	   sophisticated	   and	   non-­‐
invasive	   technique	   calculates	   balance	   between	   sympathetic	   and	   parasympathetic	   activity	   by	  
analysing	  the	  R-­‐R	  interval	  and	  the	  variation	  within	  the	  intervals	  in	  the	  epoch	  analysed.	  	  A	  number	  of	  
calculations	  of	  HRV	  have	  been	  developed	  such	  as	  the	  Root	  Mean	  Square	  of	  Successive	  RR	  Intervals	  
(RMSSD,	  see	  below),	  which	  measures	  high-­‐frequency	  vagus-­‐mediated	  HRV,	  with	  a	   low	  HRV	  highly	  
correlated	   with	   sudden	   death	   risk	   (Rauscher	   et	   al.,	   2011).	   	   A	   further	   technique,	   Fast	   Fourier	  
Transformation,	  can	  be	  used	  to	  analyse	  the	  different	  frequency	  components	  of	  the	  heart	  rate	  and	  
identify	  the	  autonomic	  mechanism	  that	  controls	  it	  (see	  Fazan	  Jr.	  et	  al.,	  2011)	  
	  
	  Initially,	   this	   study	   was	   going	   to	   explore	   heart	   rate	   variability,	   however	   due	   to	   the	  
complexity	  of	  the	  changes	  that	  occur	  during	  seizure	  this	  was	  not	  possible.	   	  The	  number	  of	  missed	  
	  	   39	  
beats	   that	   were	   observed	   during	   seizure	   meant	   that	   analysing	   the	   heart	   rate	   variability	   of	   ictal	  
periods	  was	   not	   possible.	   	   These	  missed	   beats	   were	   dramatic,	   with	   45	   (59%)	   of	   the	   76	   seizures	  
analysed	   displaying	   them,	   and	   could	   be	   lethal.	   	   This	   measure	   could,	   however,	   be	   employed	   to	  
analyse	  the	  interictal,	  pre-­‐ictal	  and	  post-­‐ictal	  periods.	  	  
Furthermore,	   in	   the	   current	   study	   only	   those	   seizures	   that	   were	   picked	   up	   by	   the	   EEG	  
electrodes	  could	  be	  identified.	  	  JJ130703	  exhibited	  wild	  running,	  a	  manifestation	  of	  epileptic	  activity	  
in	  the	  brainstem,	  however	  the	  EEG	  did	  not	  pick	  up	  any	  seizure-­‐like	  activity.	  	  The	  animal	  could	  have	  
been	  experiencing	  partial	   seizures	   in	   the	  brainstem	  or	  hippocampus	   that	   failed	   to	  generalise	  and	  
therefore	  was	  not	   picked	  up	  by	   the	   EEG	  electrodes.	   	   By	   placing	   electrodes	   into	   these	   structures,	  
seizure	  activity	  could	  be	  recorded	  however	  small.	   	  This	  would	  allow	  a	  comparison	  between	  partial	  
and	  generalised	  seizures	  and	   their	  effect	  on	   the	  cardiovascular	   system	   in	   the	  TeNT	  model	  of	  TLE,	  
exploring	  the	  differences	  already	  reported	  (Sevcencu	  and	  Struijk,	  2010).	  	  
Post-­‐mortem	   analysis	   of	   the	   animals’	   heart	  will	   also	   clarify	   the	   origins	   of	   the	   arrhythmias	  
seen	  in	  this	  study.	  	  SUDEP	  has	  been	  associated	  with	  dilated	  and	  enlarged	  hearts	  in	  humans	  (Scorza	  
et	   al.,	   2009)	   therefore,	   investigating	   the	  TeNT	   injected	  animals’	   hearts	   and	   comparing	   them	  with	  
PBS	   injected	  controls	  could	  add	  weight	  to	  the	  use	  of	  the	  model	   for	   investigating	  SUDEP.	   	  Further,	  
analysing	  the	  SAN	  for	  myocardial	  fibrosis	  and	  myofibrillar	  degeneration	  or	  evidence	  of	  ischemia	  in	  
the	  heart	  could	  help	  identify	  changes	  induced	  by	  repeated	  seizure.	  	  
Furthermore,	   the	   effect	   of	   pharmacological	   agents	   during	   seizure	   could	   also	   be	   analysed.	  	  
Firstly,	  the	  effects	  of	  the	  anti-­‐epileptic	  drugs	  carbamazepine	  and	  lamotrigine	  could	  be	  explored,	  as	  
they	  have	  both	  been	  associated	  with	  a	  higher	  risk	  of	  SUDEP	  due	  to	  their	  effect	  on	  cardiac	  function	  
(Danielsson	  et	  al.,	  2005;	  Donner,	  2011;	  Persson	  et	  al.,	  2003).	   	  This	  could	  elucidate	  whether	  or	  not	  
these	  anti-­‐epileptic	  agents	  have	  a	  detrimental	  effect	  on	  the	  rat	  cardiac	  function	  when	  injected	  with	  
TeNT.	   	  Secondly,	  antiarrhythmic	  agents	  could	  be	  explored	   to	   identify	  whether	  or	  not	   the	  seizure-­‐
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induced	  arrhythmias	  could	  be	  prevented.	  	  Thirdly,	  after	  further	  exploration	  into	  the	  seizure-­‐induced	  
changes	   to	   the	   autonomic	   system,	   therapeutic	   agents	   such	   as	   antihypertensives,	   β-­‐blockers,	  
calcium	  channel	  blockers	  and	  methyl	  atropine	  could	  be	  used	  in	  order	  to	  counteract	  the	  detrimental	  
changes	  in	  heart	  rhythm	  observed	  in	  this	  study.	  
Finally,	   each	   animal	   injected	   could	   be	   time-­‐matched	   with	   a	   control	   animal.	   	   By	   having	   a	  
control	  animal	  and	  the	  TeNT	  injected	  animal	  that	  are	  exposed	  to	  the	  same	  conditions	  would	  allow	  
for	   a	  more	   complete	   and	  accurate	   analysis,	   especially	   as	   the	  housing	   environment	   suffered	   from	  
excessive	   noise	   at	   times	   -­‐	   which	   is	   known	   to	   adversely	   affect	   TeNT	   injected	   animals.	   	   This	  
comparison	  was	  planned,	  however	  due	  to	  the	  complications	  with	  the	  later	  four	  animals	  it	  was	  not	  
possible.	  	  
Conclusion	  
In	   conclusion,	   this	   study	   observed	   cardiovascular	   changes	   induced	   by	   epileptic	   seizure.	  	  
Previous	   studies	   have	   shown	   that	   increased	   autonomic	   tone	   can	   contribute	   to	   potential	   lethal	  
arrhythmia	  generation	  (a	  risk	  factor	  for	  SUDEP).	  	  This	  study	  has	  shown	  changes	  in	  autonomic	  tone	  
with	  ictal	  bradycardia	  and	  tachycardia	  observed,	  and	  cardioarrhythmia	  generation.	  	  This	  shows	  that	  
the	   tetanus	   toxin	  model	   of	   epilepsy	   could	  be	  used	   to	   explore	   SUDEP,	   however	   the	   extent	   of	   the	  
autonomic	  changes	  observed	  and	  the	  mechanism	  of	  this	  change	  needs	  to	  be	  explored	  further.	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